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Abstract
AESOPS: a randomised controlled trial of the clinical 
effectiveness and cost-effectiveness of opportunistic 
screening and stepped care interventions for older 
hazardous alcohol users in primary care
JM Watson,1 H Crosby,2 VM Dale,1 G Tober,2 Q Wu,1 J Lang,2 
R McGovern,3 D Newbury-Birch,3 S Parrott,1 JM Bland,1 C Drummond,4 
C Godfrey,1 E Kaner3 and S Coulton5* on behalf of the AESOPS trial team
1Department of Health Sciences, University of York, York, UK
2Leeds Addiction Unit, Leeds, UK
3Institute of Health and Society, Newcastle University, Newcastle, UK
4National Addiction Centre, Institute of Psychiatry, King’s College London, London, UK
5Centre for Health Service Studies, University of Kent, Canterbury, UK
*Corresponding author S.Coulton@kent.ac.uk
Background: There is clear evidence of the detrimental impact of hazardous alcohol consumption on the 
physical and mental health of the population. Estimates suggest that hazardous alcohol consumption 
annually accounts for 150,000 hospital admissions and between 15,000 and 22,000 deaths in the UK. In 
the older population, hazardous alcohol consumption is associated with a wide range of physical, 
psychological and social problems. There is evidence of an association between increased alcohol 
consumption and increased risk of coronary heart disease, hypertension and haemorrhagic and ischaemic 
stroke, increased rates of alcohol-related liver disease and increased risk of a range of cancers. Alcohol is 
identified as one of the three main risk factors for falls. Excessive alcohol consumption in older age can 
also contribute to the onset of dementia and other age-related cognitive deficits and is implicated in one-
third of all suicides in the older population.
Objective: To compare the clinical effectiveness and cost-effectiveness of a stepped care intervention 
against a minimal intervention in the treatment of older hazardous alcohol users in primary care.
Design: A multicentre, pragmatic, two-armed randomised controlled trial with an economic evaluation.
Setting: General practices in primary care in England and Scotland between April 2008 and 
October 2010.
Participants: Adults aged ≥ 55 years scoring ≥ 8 on the Alcohol Use Disorders Identification Test (10-item) 
(AUDIT) were eligible. In total, 529 patients were randomised in the study.
Interventions: The minimal intervention group received a 5-minute brief advice intervention with the 
practice or research nurse involving feedback of the screening results and discussion regarding the health 
consequences of continued hazardous alcohol consumption. Those in the stepped care arm initially 
received a 20-minute session of behavioural change counselling, with referral to step 2 (motivational 
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enhancement therapy) and step 3 (local specialist alcohol services) if indicated. Sessions were recorded and 
rated to ensure treatment fidelity.
Main outcome measures: The primary outcome was average drinks per day (ADD) derived from 
extended AUDIT – Consumption (3-item) (AUDIT-C) at 12 months. Secondary outcomes were AUDIT-C 
score at 6 and 12 months; alcohol-related problems assessed using the Drinking Problems Index (DPI) at 6 
and 12 months; health-related quality of life assessed using the Short Form Questionnaire-12 items (SF-12) 
at 6 and 12 months; ADD at 6 months; quality-adjusted life-years (QALYs) (for cost–utility analysis derived 
from European Quality of Life-5 Dimensions); and health and social care resource use associated with the 
two groups.
Results: Both groups reduced alcohol consumption between baseline and 12 months. The difference 
between groups in log-transformed ADD at 12 months was very small, at 0.025 [95% confidence interval 
(CI) –0.060 to 0.119], and not statistically significant. At month 6 the stepped care group had a lower 
ADD, but again the difference was not statistically significant. At months 6 and 12, the stepped care group 
had a lower DPI score, but this difference was not statistically significant at the 5% level. The stepped care 
group had a lower SF-12 mental component score and lower physical component score at month 6 and 
month 12, but these differences were not statistically significant at the 5% level.
The overall average cost per patient, taking into account health and social care resource use, was £488 
[standard deviation (SD) £826] in the stepped care group and £482 (SD £826) in the minimal intervention 
group at month 6. The mean QALY gains were slightly greater in the stepped care group than in the 
minimal intervention group, with a mean difference of 0.0058 (95% CI –0.0018 to 0.0133), generating an 
incremental cost-effectiveness ratio (ICER) of £1100 per QALY gained. At month 12, participants in the 
stepped care group incurred fewer costs, with a mean difference of –£194 (95% CI –£585 to £198), and 
had gained 0.0117 more QALYs (95% CI –0.0084 to 0.0318) than the control group. Therefore, from an 
economic perspective the minimal intervention was dominated by stepped care but, as would be expected 
given the effectiveness results, the difference was small and not statistically significant.
Conclusions: Stepped care does not confer an advantage over minimal intervention in terms of reduction 
in alcohol consumption at 12 months post intervention when compared with a 5-minute brief (minimal) 
intervention. 
Trial registration: This trial is registered as ISRCTN52557360.
Funding: This project was funded by the NIHR Health Technology Assessment programme and will be 
published in full in Health Technology Assessment; Vol. 17, No. 25. See the HTA programme website for 
further project information.
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Scientific summary
Background
There is clear evidence of the detrimental impact of hazardous alcohol consumption on the physical 
and mental health of the population. Estimates suggest that hazardous alcohol consumption annually 
accounts for 150,000 hospital admissions and between 15,000 and 22,000 deaths in the UK. In the older 
population, hazardous alcohol consumption is associated with a wide range of physical, psychological 
and social problems. There is evidence of an association between increased alcohol consumption and 
increased risk of coronary heart disease, hypertension, haemorrhagic and ischaemic stroke, increased rates 
of alcohol-related liver disease and increased risk of a range of cancers. Alcohol has been identified as one 
of the three main risk factors for falls. Excessive alcohol consumption in older age can also contribute to 
the onset of dementia and other age-related cognitive deficits and is implicated in one-third of all suicides 
in the older population.
Objectives
To compare the clinical effectiveness and cost-effectiveness of a stepped care intervention against a 
minimal intervention in the treatment of older hazardous alcohol users in primary care.
Design
A multicentre, pragmatic, two-armed randomised controlled trial with an economic evaluation. 
Randomisation was performed by a remote service. Treating nurses, therapists and participants were aware 
of allocation result, and outcome assessment was average drinks per day (ADD) derived from the extended 
Alcohol Use Disorders Identification Test – Consumption (3-item) (AUDIT-C).
Setting
General practices in primary care in England and Scotland.
Participants
Participants were eligible to participate in the study if they were aged ≥ 55 years and scored ≥ 8 on the 
Alcohol Use Disorders Identification Test (AUDIT). Following screening, a total of 529 participants were 
randomised in the study.
Interventions
Participants in the minimal intervention group received a 5-minute brief advice intervention with the 
practice nurse or research nurse involving feedback of the results of the screening and discussion regarding 
the health consequences of continued hazardous alcohol consumption. Those in the stepped care arm 
initially received a 20-minute session of behavioural change counselling (step 1), with referral to step 2 
(motivational enhancement therapy) and step 3 (local specialist alcohol services) if indicated. Sessions were 
recorded to ensure treatment fidelity.
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Main outcome measures
The primary outcome was ADD derived from the extended AUDIT-C at 12 months. Secondary outcomes 
were alcohol-related problems assessed using the Drinking Problems Index (DPI) at 6 and 12 months; ADD 
(derived from the extended AUDIT-C) at 6 months; extended AUDIT-C score at 6 and 12 months; health-
related quality of life (HRQoL) at 6 and 12 months; quality-adjusted life-years (QALYs) (for cost–utility 
analysis derived from European Quality of Life-5 Dimensions); and health and social care resource use 
associated with the two groups.
Results
Both groups reduced alcohol consumption between baseline and 12 months. There were no significant 
differences in ADD between the treatment groups at 12 months. Stepped care had a marginally higher 
ADD [1.129; standard deviation (SD) 0.037] than minimal intervention (1.104; SD 0.037), but not 
significantly so. At months 6 and 12, the stepped care group had a lower DPI score than the minimal 
intervention group, but the difference was not statistically significant at the 5% level. At month 6, the 
stepped care group had a lower ADD than the minimal intervention group, but this difference was not 
statistically significant. The stepped care group had a lower mental component score [measured using 
the Short Form Questionnaire-12 items (SF-12)] than the minimal intervention group at month 6 and 
month 12. The stepped care group also had a lower physical component score at month 6 and month 12. 
These differences were not significant at the 5% level.
The cost-effectiveness results indicated that the overall average cost per patient, taking into account health 
and social care resource use, was £488 (SD £826) in the stepped care group and £482 (SD £826) in the 
minimal intervention group at month 6. The mean QALY gains were slightly greater in the stepped care 
group than in the minimal intervention group, with a mean difference of 0.0058 [95% confidence interval 
(CI) –0.0018 to 0.0133], generating an incremental cost-effectiveness ratio (ICER) of £1100 per QALY 
gained. At month 12, participants in the stepped care group incurred fewer costs, with a mean difference 
of –£194 (95% CI –£585 to £198), and had gained 0.0117 more QALYs (95% CI –0.0084 to 0.0318) than 
the control group. From an economic perspective the minimal intervention, therefore, was dominated 
by stepped care. Given thresholds of £20,000–30,000 per additional QALY gained, the probability that 
stepped care is more cost-effective is 81–86% at the 6-month follow-up and 93.5–93.8% at 12 months.
A sensitivity analysis that excluded extreme cases altered the average costs of interventions; the ICERs 
were £8496 per QALY at 6 months and £4224 per QALY at 12 months. The probability that stepped 
care is more cost-effective ranges between 80% and 88% at 6 months, and between 87% and 90% at 
12 months, using the £20,000–30,000 per QALY gained threshold.
The prevalence of hazardous alcohol consumption in those aged ≥ 55 years had been estimated at 15% 
in the general population. Screening results from this study found this to be only 7.5%. Fidelity process 
rating identified significant differences between the minimal and step 1 interventions, indicating that the 
two types of intervention were distinct. There were no significant differences in the rating scores between 
practice or research nurses with different levels of experience (specialist vs non-specialist practitioners).
Conclusions
Stepped care does not confer an advantage over minimal intervention in terms of reduction in alcohol 
consumption at 12 months post intervention when compared with a 5-minute brief (minimal) intervention. 
Our cost-effectiveness analysis examining QALY gains suggested that the stepped care intervention is more 
likely to generate greater health benefits and achieves better value for money compared with minimal 
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intervention, but caution is required given the uncertainty surrounding the estimates and the absence of a 
statistically significant difference in effectiveness outcomes.
Implications for health care
There is no evidence that a stepped care approach reduces alcohol consumption in terms of ADD among 
older hazardous alcohol users after 12 months, or improves AUDIT score, alcohol-related problems or 
quality of life after 6 or 12 months.
Recommendations for future research
The experience of conducting this study alongside the results obtained has prompted a number of 
suggestions for future research:
 z What factors facilitate or hinder the conduct of research in primary care settings?
 z What is the clinical effectiveness and cost-effectiveness of community-based screening and self-
directed ultra-brief interventions for hazardous alcohol users compared with screening alone?
 z What is the clinical effectiveness and cost-effectiveness of motivational enhancement therapy for 
opportunistically identified, non-treatment-seeking harmful alcohol users delivered in primary care?
 z What are the longer-term clinical and economic impacts of stepped care interventions?
Study registration
This trial is registered as ISRCTN52557360.
Funding
This project was funded by the NIHR Health Technology Assessment programme and will be published 
in full in Health Technology Assessment; Vol. 17, No. 25. See the HTA programme website for further 
project information.
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Chapter 1 Background
There exists a wealth of evidence regarding the detrimental impact of hazardous alcohol consumption on the physical and mental health of the population [hazardous alcohol consumption is defined as the 
consumption of more than 21 standard alcohol units in any week for males and 14 for females; or half 
of the recommended number of standard alcohol units in any one day (10 for males, 7 for females)]. It is 
estimated that hazardous alcohol consumption accounts for 150,000 hospital admissions and between 
15,000 and 22,000 deaths per annum in the UK.1 In the older population (those aged ≥ 55 years), 
hazardous alcohol consumption is associated with a wide range of physical, psychological and social 
problems.2 There is evidence of an association between increased alcohol consumption and increased 
risk of coronary heart disease, hypertension and haemorrhagic and ischaemic stroke, increased rates of 
alcohol-related liver disease and increased risk of a range of cancers.3 Alcohol consumption is identified as 
one of the three main risk factors for falls,4 a major cause of morbidity and mortality in this population. 
The Royal College of Physicians estimates that 60% of older people admitted to hospital because of 
repeated falls, confusion, chest infections and heart failure have undiagnosed alcohol problems.5 Increased 
alcohol consumption in older age can also contribute to the onset of dementia and other age-related 
cognitive deficits, Parkinson’s disease and a range of psychological problems including depression and 
anxiety.6 Alcohol use is implicated in one-third of all suicides in the older population.7 It is estimated that 
80% of those aged ≥ 65 years regularly take prescribed medication and that polypharmacy is common, 
with one-third taking at least four prescribed medications per day.8 Alcohol is a major contraindication for 
many of the drugs prescribed for older people, and alcohol and medication interactions are a common 
phenomenon.9 Increased alcohol consumption in older age is also associated with a range of social 
problems including self-neglect, poor nutrition, social isolation and hypothermia.10
The prevalence of hazardous alcohol consumption (inclusive of harmful consumption) in those aged 
≥ 55 years is generally considered to be lower than in the wider adult population. The most recent estimate 
derived from the Alcohol Needs Assessment Research Project11 indicates a general population prevalence 
of between 15% and 25% and concurs with other estimates derived from the General Household Survey.12 
There is evidence that these prevalence rates are underestimates of the true prevalence rate.11 There is also 
evidence that the prevalence rate in primary care attendees is higher than in the general population.13 
Furthermore, the current Home Office Alcohol Strategy recommends that available research be used 
in order to understand ‘how we can best communicate the risks from alcohol, improving the public’s 
understanding of both personal risks and societal harms. This will include whether separate advice is 
desirable for the maximum amount of alcohol to be drunk in one occasion and for people over 65’.14
Recent research using data derived from the General Practice Research Database indicates that only 5% of 
people aged ≥ 55 years with an alcohol use disorder are identified in primary care settings.15 Older people 
are less likely to seek treatment for alcohol use disorders16 and alcohol-related presentations are often 
atypical or masked by comorbid physical or psychiatric illness that makes alcohol-related diagnosis more 
difficult.17 In 2000, 16% of the UK population was ≥ 65 years old and this is expected to increase to 21% 
by 2026.8 As the average age of the population increases, the absolute number of older people consuming 
alcohol at hazardous levels will increase even if the prevalence rate remains stable. Opportunistic screening 
is a proactive screening technique that has been used with some success in a variety of health-care areas 
including type II diabetes18 and chlamydia infections,19 and is particularly useful in identifying conditions in 
populations who would not usually seek treatment.
A number of paper-based screening methods have been developed to identify hazardous alcohol 
consumption; these include instruments such as the Michigan Alcohol Screening Test,20 Paddington 
Alcohol Test,21 Fast Alcohol Screening Test,22 Single Alcohol Screening Question23 and the Alcohol Use 
Disorders Identification Test (AUDIT).24 All have acceptable levels of sensitivity and specificity. The AUDIT 
was specifically developed for use in a primary care population and has 92% sensitivity and 92% specificity 
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for identifying hazardous alcohol use in a UK primary care setting.13 More specifically, in older populations 
(≥ 65 years) AUDIT has been demonstrated to have higher sensitivity and specificity compared with 
other screening tests.25 AUDIT is a short, 10-item questionnaire that addresses frequency of alcohol 
consumption, alcohol-related problems and alcohol dependence symptoms. Because of the evidence 
of underdetection and misdiagnosis of hazardous alcohol use in older populations,16,17 the proactive 
application of a short universal screening method is likely to be more appropriate. There is evidence that 
patients are more compliant with screening protocols for alcohol use in health-care settings and that the 
environment provides an opportunity for a ‘teachable moment’, increasing the patient’s likelihood of 
engaging in any intervention.26
There is a substantial evidence base for the efficacy of brief motivational interventions, aimed at reducing 
alcohol consumption in primary care. Studies have demonstrated the effectiveness of brief interventions 
in reducing alcohol consumption in primary care populations in the UK;27 in particular, six systematic 
reviews focus specifically on this28–33 and all conclude that brief interventions in primary care populations 
are effective in reducing alcohol consumption. However, many of the studies included in these reviews 
exclude older patients. There are no systematic reviews or subgroup analyses specifically focusing on older 
patient groups. There is contradictory evidence from primary research of the efficacy of brief interventions 
specifically targeted at older hazardous alcohol consumers. Moore et al.34 compared a minimal, brief 
advice intervention with a multifaceted intervention including physician advice and behavioural counselling 
in adults attending primary care centres in the USA. While reductions were observed in both groups in 
terms of consumption at 12 months, no significant differences were observed between the groups. Yet 
in a trial of brief interventions for older alcohol users in primary care in the USA, Fleming et al.35 reported 
a 34% reduction in alcohol consumption and 64% reduction in those drinking at hazardous levels at 
12 months, significantly better than those who received no intervention. Blow and Barry36 also reported 
significantly greater reduction in alcohol use in older people treated with brief interventions in primary 
care than in control subjects. There is also evidence from subgroup analyses of existing studies that older 
patients are at least as likely to benefit from brief interventions as younger patients37 and that older adults 
are more likely to adhere to and comply with brief intervention treatment regimes.38
Brief interventions have been proven to be both clinically effective and cost-effective in the management 
of individuals with hazardous and harmful drinking in primary care settings.27–29,39 Existing studies, 
however, have included few older drinkers, and this population may have different alcohol problems and, 
consequently, different health and social costs. The evidence of brief interventions has been criticised for 
failing to address a wider range of alcohol use disorders including harmful alcohol consumption40 and for 
failing to address more entrenched drinking behaviours.
Screening for alcohol use disorders identifies a range of needs that are likely to require a range of types 
and intensities of interventions. One of the primary reasons why many general practitioners (GPs) are 
reluctant to implement screening into routine care is because they lack the appropriate skills for dealing 
with the more severe cases identified.41
Older alcohol consumers are often typified as either ‘early-onset’ drinkers, whose consumption pattern 
is a continuation of lifetime hazardous consumption, or ‘late-onset’ drinkers, whose excessive alcohol 
consumption begins in later life. ‘Late-onset’ drinkers are more likely to benefit from brief interventions 
than ‘early-onset’ drinkers, who often require a more intensive intervention approach.42 One such intensive 
approach that has been used is motivational enhancement therapy (MET). It is relatively short (usually 
three 40-minute sessions delivered by a trained therapist) but is more intensive than a brief motivational 
intervention. Primary research has shown it to be as effective as other even more intensive interventions 
such as Cognitive Behavioural Therapy, Twelve-Step Facilitation Therapy and Social Behavioural Network 
Therapy [Matching Alcohol Treatments to Client Heterogeneity (Project MATCH)43; UK Alcohol Treatment 
Trial (UKATT)44].
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Physiological changes that occur as part of the ageing process mean that older people are more vulnerable 
to the effects of alcohol and experience alcohol-related problems at lower consumption levels than 
younger people. Stepped care interventions offer a potentially resource-efficient means of meeting 
the needs of this population. Stepped care interventions provide a means of delivering more intensive 
interventions only to those who fail to respond to less intensive interventions, and are more in keeping 
with rational clinical decision-making than the blanket use of any one intervention strategy. This stepped 
approach has been advocated in a variety of clinical areas including depression,45,46 smoking,47 back pain48 
and alcohol use.49,50 A recent pilot study of stepped care interventions for male alcohol users in primary 
care indicated a potential effect size difference between stepped care and minimal intervention of 0.25 
in favour of stepped care and an indication that stepped care approaches for alcohol users may be more 
cost-effective than minimal interventions.51
Research objectives
 z To evaluate the clinical effectiveness and cost effectiveness of stepped care interventions for older 
hazardous alcohol users in primary care.
 z To screen 4170 primary care attendees aged ≥ 55 years for hazardous alcohol use using the 
AUDIT questionnaire.
 z To evaluate the acceptability and validity of opportunistically screening for hazardous alcohol use in 
older primary care attendees.
 z To estimate the prevalence of alcohol use disorders in an older primary care population.
 z To study the process of therapy as delivered by both practice nurses and trained therapists.
 z To randomise 500 hazardous alcohol users, with equal probability, to either a minimal intervention or 
stepped care.
 z To conduct 6- and 12-month follow-up on at least 70% of those randomised to assess alcohol 
consumption, alcohol-related problems, quality of life and service utilisation.
Primary hypothesis (stated as a null hypothesis)
 z Stepped care interventions for older hazardous alcohol users are no more effective at reducing alcohol 
consumption than a minimal intervention 12 months after randomisation.
Secondary hypotheses (stated as a null hypothesis)
 z Stepped care is no more cost-effective than minimal intervention 12 months after randomisation.
 z Stepped care will not reduce alcohol-related problems in comparison with minimal intervention 
12 months after randomisation.
 z Stepped care will not increase health-related quality of life (HRQoL) compared with minimal 
intervention 12 months after randomisation.
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Chapter 2 Methods
Trial design
The Alcohol: Evaluating Stepped care in Older Populations Study (AESOPS) was a pragmatic, multicentre, 
two-armed, randomised controlled, open trial with equal randomisation. Participants aged ≥ 55 years who 
scored ≥ 8 using the AUDIT and consented to participate were randomised (1 : 1) to receive either:
 z minimal intervention consisting of a 5-minute brief advice intervention with the practice nurse or 
research nurse involving feedback of the results of the screening and discussion regarding the health 
consequences of continued hazardous alcohol consumption; or
 z stepped care intervention consisting of three consecutive steps, in which progression between steps is 
dependent upon the outcome of each previous step.
The study protocol can be seen in Appendix 1.
Sample size
At the time of development, there were no previous studies of stepped care interventions for older alcohol-
using adults. The closest UK pragmatic randomised controlled trials (RCTs) include that by Wallace et al.27 
and STEPWICE,52 which reported effect size differences between stepped care and minimal interventions 
of 0.36 and 0.27 respectively. Similar effect size differences were reported in studies from the USA.35,53,54 
There is evidence that older populations respond to brief psychosocial interventions for alcohol use as well 
as, or even better than, general populations.38,55 Assuming a conservative effect size difference between 
stepped care and minimal intervention of the order of 0.3 would require a sample size of 175 participants 
in each of the two randomised groups, using power at 80% and a 5% significance level.
Our previous experience in conducting RCTs in the fields of substance use, alcohol-using populations44,52 
and elderly populations indicated that, with assiduous follow-up regimes, loss to follow-up at 12 months 
would be in the order of 20%. Evidence also exists that older populations are more compliant with 
treatment regimes and follow-up protocols than younger populations.56 Taking these factors into account, 
we erred on the side of caution and allowed a loss to follow-up of 30%, requiring 500 participants to be 
randomised (250 in each group). Previous alcohol use screening and intervention studies conducted in UK 
health-care settings57 suggest that 80% of those screened positive tend to be eligible and 75% of those 
eligible tend to consent to randomisation. This meant that the study required 834 screen-positives, of 
whom we predicted 500 would be eligible and consent to randomisation.
Approvals obtained
North West Research Ethics Committee approved the study on 11 April 2007.
The details of multicentre research ethics committee, local research ethics committee and Research and 
Development Department approvals are provided in Appendix 2.
The trial was assigned the International Standard Randomised Controlled Trial Number (ISRCTN) of 
ISRCTN52557360; National Research Register number N0484190633 and United Kingdom Clinical 
Research Network ID 3796.
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Trial sites
The study was conducted in eight UK sites with 55 general practices set up to participate. These sites and 
practices were recruited throughout the study and represent a range of small and large practices, and 
urban and rural settings. The sites included were North Yorkshire and York; Hull and East Riding; Norfolk; 
Leeds; Fife; Kent; Tyneside; and County Durham. Details of the study sites and practices are provided in 
Appendix 3.
Participant eligibility
Inclusion and exclusion criteria were chosen to maintain a balance between ensuring the sample was 
representative of the primary care population and ensuring that the trial population was able to engage 
with both the interventions and follow-up.
Inclusion criteria
Patients were considered potentially eligible if they met all of the following criteria:
1. They were aged ≥ 55 years at time of screening.
2. They screened positive for hazardous alcohol use (this is inclusive of harmful and dependent alcohol 
use) using AUDIT criteria (i.e. scored ≥ 8).
3. They provided their contact details on the screening form.
4. They were residing in a stable place of residence.
5. They lived within commutable distance of the primary care centre.
6. They were willing to provide informed consent for randomisation, treatment and follow-up.
Exclusion criteria
Potential participants were excluded if they met any of the following criteria:
1. They had received treatment for substance use, excluding nicotine, in the previous 90 days.
2. They were already seeking help for alcohol use.
3. They had any outstanding legal issues likely to lead to imprisonment.
4. They suffered from severe mental or physical illness likely to preclude active participation in treatment 
or follow-up.
Recruitment into the trial
All primary care attendees aged ≥ 55 years were given the opportunity to pick up a ‘screening pack’ from 
the practice waiting room or from the receptionist. The screening pack contained an information sheet 
(Appendix 4), a copy of the AUDIT questionnaire (Appendix 5) and a freepost return envelope. The AUDIT 
questionnaire contained a section asking for contact details to be provided if the patient was willing 
to help with the research; thereby, patients had the opportunity to complete the form anonymously. 
This envelope could either be posted back to the University of York (allowing for completion at home 
if preferred) or left in a postal box within the GP practice. Returned questionnaires were entered into a 
secure online database that collated the responses to all 10 questions on the AUDIT questionnaire. Patients 
who scored ≥ 8 on the AUDIT questionnaire, and had provided their contact details, were contacted 
by telephone and invited to attend an appointment with the practice/research nurse, ideally within the 
following 7 days. At that point they had the opportunity to ask any questions. At the appointment, the 
study was fully explained to the patients, their eligibility to participate was ascertained and they were given 
an opportunity to ask any further questions. If interested and willing, they were then asked to give written 
informed consent.
© Queen’s Printer and Controller of HMSO 2013. This work was produced by Watson et al. under the terms of a commissioning contract issued by the Secretary of State for 
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
DOI: 10.3310/hta17250 HealtH tecHnOlOgy assessment 2013 VOl. 17 nO. 25
7
During the study recruitment phase, a change in screening method was brought in (detailed in Chapter 3). 
In addition to the opportunistic screening method, all potentially eligible participants received screening 
packs by mail from their general practice. This revised method was implemented in some of those 
practices already screening opportunistically and in all new practices brought on board after the change 
was implemented.
Baseline assessment
After written informed consent had been obtained, the following data were collected in the baseline 
questionnaire (Appendix 6) prior to randomisation.
Alcohol Use Disorders Identification Test – Consumption (3-item)
This consists of the first three alcohol consumption questions from the AUDIT 10-item scale.24
Drinking Problem Index
Alcohol-related problems were assessed using the 17-item participant-completed Drinking Problems Index 
(DPI). The DPI has been specifically designed and validated for use in older populations.58
Health-related quality of life
Participants were given a baseline questionnaire to complete, comprising the Short Form Questionnaire-12 
items (SF-12)59 and European Quality of Life-5 Dimensions (EQ-5D).60
Health and social resource used
Details regarding hospital and primary health-care services use, social and care services use and contact 
with the police and criminal justice system were collected. The service use questionnaire covered a 
retrospective 6-month period.
Demographics
Details on age, sex, smoking status, main activity, living arrangements, current accommodation and 
education were collected.
Randomisation
Participants were randomised equally between the two trial arms: minimal intervention and stepped 
care intervention. Randomisation was carried out using random permuted blocks, stratified by site 
(North Yorkshire and York; Hull and East Riding; Norfolk; Leeds; Fife; Kent; Tyneside; or County Durham). 
To maintain allocation concealment, the generation of the randomisation sequence and subsequent 
treatment allocation were performed by an independent, secure, remote, telephone randomisation 
service based at the University of York. The computerised randomisation system was checked periodically 
during the trial following standard operating procedures. Owing to the nature of the intervention and 
the pragmatic aim of the evaluation, treatment allocation, once determined, was not concealed from the 
participant or the professional delivering the intervention.
Trial interventions
Participants were randomised to receive either:
 z minimal intervention: a 5-minute brief advice intervention with the practice nurse or research nurse 
involving feedback of the results of the screening and discussion regarding the health consequences of 
continued hazardous alcohol consumption; or
 z stepped care intervention: consisting of three consecutive steps, in which progression between steps is 
dependent upon the outcome of each previous step.
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Intervention delivery
Originally, in some practices, the practice nurse delivered the minimal intervention and step 1 of the 
stepped care intervention. In other practices, a research nurse or research practitioner took on this role. 
Following a change to the protocol (as detailed in Chapter 3), two new sites used an alcohol health 
worker. For the purpose of this report, those delivering the minimal intervention and step 1 of the stepped 
care intervention will be referred to as the ‘practice/research nurses’.
In the majority of sites, step 2 was delivered by a different person than step 1. In four sites, the same 
people delivered the minimal intervention and steps 1 and 2 of the stepped care interventions. For the 
purpose of this report, those delivering step 2 of the stepped care intervention will be referred to as 
the ‘therapists’.
The set-up of the intervention delivery in each site is detailed in Appendix 7.
Training in the delivery of the minimal intervention and step 1 
(behavioural change counselling)
The training was delivered by the training centre at Leeds Addiction Unit and lasted either 1 or 2 days, 
depending on previous experience of the staff being trained. Training for the minimal intervention involved 
understanding the AUDIT instrument and interpreting the score, and practice in feeding this back to 
participants and making recommendations for reducing consumption. It was delivered before training for 
the step 1 (20-minute) intervention that encompassed motivational interviewing skills, feeding back AUDIT 
scores in a manner that is designed to elicit concerns, and negotiating a behaviour change goal. In both 
cases training was supported by a written protocol. The training took the form of simulated consultation, 
followed by a seminar and then another simulated consultation. Each attendee had the opportunity 
to engage in a simulated consultation and this was recorded. As a group the practice/research nurses 
discussed the simulated consultations to examine and review the techniques. Prior to the staff seeing any 
study participants, an assessment of their competency was made using a recorded session that was rated 
by an independent expert. Ongoing supervision was provided throughout the study by an expert trainer 
from Leeds Addiction Unit.
A further training session was provided covering protocol issues and use of the study database. This 
session included the rationale for the study; patient eligibility; use of the online database (making 
and recording outcomes of appointments); recruitment procedures (including informed consent and 
randomisation); completion of trial documentation; conducting post-step 1 and post-step 2 assessment 
telephone calls; and handling of participant withdrawal.
Training in the delivery of step 2 (motivational enhancement therapy)
Motivational enhancement therapy therapists had attended specialist training at the Leeds Addiction Unit. 
Training was supported by a MET protocol, and follow-up supervision of video-recorded supervision was 
offered. Particular attention was given to understanding of the evidence base, the theoretical basis of 
treatment, demonstration of practice and role-play opportunities. Supervision was given in the delivery of a 
number of therapy sessions, and two recorded sessions were to be completed and reviewed in conjunction 
with a trained supervisor prior to the therapist seeing study participants. The supervision provided the main 
opportunity for practising skills and delivering the structure and content of the treatment. Assessment 
of competence was considered according to the therapist’s ability to deliver MET in accordance with the 
designation of treatment prescribed in the treatment protocol.
A further training session was provided covering protocol issues and use of the study database. This 
session included the rationale for the study; patient eligibility; use of the online database (making and 
recording outcome of appointments); and handling of participant withdrawal.
© Queen’s Printer and Controller of HMSO 2013. This work was produced by Watson et al. under the terms of a commissioning contract issued by the Secretary of State for 
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
DOI: 10.3310/hta17250 HealtH tecHnOlOgy assessment 2013 VOl. 17 nO. 25
9
Minimal intervention arm
The minimal intervention consisted of a 5-minute brief advice intervention with the practice/research nurse 
involving feedback of the results of the screening and discussion regarding the health consequences of 
continued hazardous alcohol consumption. The participant also received a brief self-help booklet, Safer 
drinking – a self help guide (Appendix 8), outlining the consequences of excessive alcohol consumption 
and providing information on sources of help for drinking problems locally and nationally.
Stepped care intervention arm
The stepped care intervention consisted of three consecutive steps in which progression between steps was 
dependent upon the outcome of each previous step.
Step 1 consisted of a 20-minute session of behavioural change counselling (BCC) delivered by the practice/
research nurse. This intervention, based upon an existing evidence base of brief interventions, utilises the 
technique of motivational interviewing40 and aims to address the individual’s motivation to change his or 
her drinking behaviour. The counselling was protocol guided and the practice/research nurses were trained 
in the delivery. Four weeks after randomisation the participant was contacted by the nurse and a short 
telephone assessment was made regarding the participant’s alcohol consumption in the previous 4 weeks 
using the extended AUDIT–Consumption (3-item) (AUDIT–C). If the participant was still consuming alcohol 
at hazardous levels a referral was made to step 2 of the intervention.
Step 2 involved an intervention by a trained therapist in the primary care environment. The intervention, 
MET, was provided through three 40-minute sessions on, preferably, a weekly basis if possible. The 
intervention was protocol guided and addressed six basic principles of increasing motivation for change. 
Feedback about individual alcohol consumption included emphasis on the individual as being the agent 
responsible to change, advice on how to accomplish change, provision of alternative vehicles for change, 
maintenance of an empathetic therapeutic style and emphasis on enhancing the individual’s self-efficacy. 
Four weeks after the final MET session, the nurse contacted the participant and a short telephone 
assessment was made regarding the participant’s alcohol consumption in the previous 4 weeks using the 
extended AUDIT-C. If the participant was still consuming alcohol at hazardous levels a referral was to be 
made to step 3 of the intervention.
These interventions were guided by treatment protocols to specify the purpose and principles of each 
intervention and the structure and content of each particular treatment session.
Step 3 consisted of a referral to the local specialist alcohol services to receive specialist intervention, 
including, as necessary, detoxification, inpatient care, outpatient counselling, group therapy, 
relapse prevention treatment or medication. There was no limit on the intensity or duration of the 
step 3 intervention.
Participant follow-up
Appendix 9 shows a summary of the AESOPS trial.
Trial completion
Participants were deemed to have completed the trial when they had been in the trial for 12 months.
Participants were deemed to have fully withdrawn from the trial when:
 z they wished to exit the trial fully
 z their doctor or nurse withdrew them from the trial or
 z they died.
Instead of withdrawing fully from the trial, participants had the option of (1) withdrawing only from 
receiving trial treatment; or (2) withdrawing only from postal questionnaires.
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Participants who elected to withdraw from both the trial treatment and the follow-up postal 
questionnaires were deemed to be full withdrawals. This ensured appropriate follow-up from the 
Trials Unit.
Measurement and verification of primary measure
The primary outcome measure was average drinks per day (ADD) at 12 months post randomisation, where 
a standard drink equates to 8 g of ethanol.
Determination of average drinks per day
This was ascertained using the self completed extended AUDIT-C. The outcome was measured at baseline 
and then at 6 and 12 months post randomisation.
Measurement and verification of secondary outcomes
Alcohol-related problems
Alcohol-related problems were measured at baseline, 6 and 12 months post randomisation using the 
17-item DPI.
Health-related quality of life
Participants were asked to answer questions relating to their HRQoL throughout the study by completing 
two generic instruments (EQ-5D and SF-12). These instruments are particularly useful for comparing 
groups of participants while also having a broad capacity for use in economic evaluation. Their generic 
nature also makes them potentially responsive to side effects or unforeseen effects of treatment.
Each participant’s perception of his or her general health was assessed using the acute version of the 
SF-1261 and the EQ-5D.60 The SF-12 is a reliable and well-validated questionnaire,62 and has been used 
in UK populations, including with older people.63 We used a layout of the SF-12 shown in previous work 
to yield improved response rates and quality.64 The EQ-5D is a generic measure of health status, where 
health is characterised on five dimensions (mobility, self-care, ability to undertake usual activities, pain and 
anxiety/depression).60 Participants were asked to describe their level of health on each dimension using 
one of three levels: no problems, moderate problems and severe problems. Each response locates a person 
in one of 245 mutually exclusive health states (the 243 states arising from the EQ-5D, plus unconscious 
and dead), each of which has previously been valued on the 0 (equivalent to dead) to 1 (equivalent to 
perfect health) ‘utility’ scale based on interviews with a sample of 3395 members of the UK public.65 The 
EQ-5D has been validated in the UK and questionnaires containing both instruments were administered to 
participants in person at baseline and by postal questionnaire at 6 and 12 months.
Collection of resource-use data
At recruitment (baseline) and 6 and 12 months after randomisation, participants were asked to complete 
a questionnaire on health and social care resource use during the previous 6 months (Appendix 6). The 
questionnaire was designed for participant completion and was returned to the trial office using a prepaid 
reply envelope. Participants indicated how many times in the previous 6 months they had used health 
services, for example if they had seen a GP or nurse or received hospital care. In addition, they were asked 
about contact with the police and criminal justice system. The collection of self-reported resource-use data 
was continued until the patient had been in the study for 12 months or until the patient withdrew from 
follow-up, or fully withdrew from the study.
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Quality assurance of treatment delivery
Participants were asked to provide consent to have all treatment sessions recorded. A 30% sample was 
randomly selected, stratified by therapist, site and treatment (minimal and stepped care). Recordings 
were rated by an independent rater and assessed for quality of delivery and compliance with treatment 
protocols. A proportion of the recordings were double rated for quality assurances and calibration.
Adverse events
There were no anticipated risks in relation to either treatment arm and there is no documented evidence 
of adverse events arising as a result of either minimal intervention or stepped care intervention, but a 
mechanism for recording these was in place in case any arose.
Non-trial participants
Patients who had returned their screening forms and entered their contact details indicating willingness 
to be approached, but were subsequently found not to be eligible based on their AUDIT score (i.e. they 
scored < 8), were sent a letter informing them of the outcome of the screening. In addition, a ‘non-
participant’ questionnaire identical to the study baseline questionnaire was included and patients were 
asked to complete this if they so wished and return it anonymously (Appendix 6).
Clinical analyses methods
The objective of the clinical analyses was to compare the clinical effectiveness and cost-effectiveness of 
stepped care interventions for older hazardous alcohol users in primary care.
Outcomes
Primary
 z Average drinks per day – derived from extended AUDIT-C at 12 months. The number of times per 
week alcohol was consumed was calculated from question 1 of the AUDIT-C. This was multiplied by 
the number of standard drinks reported in question 2 and then divided by 7 to give the ADD. For 
example, drinking four or five times per week would give a mean number of 4.5 days. If the number 
of standard drinks stated was 7–9, the number of standard drinks would be taken as the midpoint, 8. 
The calculation would then be 4.5 × 8/7 = 5.1 drinks per day.
Secondary
 z Alcohol-related problems (DPI) at 6 and 12 months.
 z Quality of life (SF-12) at 6 and 12 months.
 z ADD (derived from extended AUDIT-C) at 6 months.
 z Extended AUDIT-C score at 6 and 12 months.
 z AUDIT-C status at 6 and 12 months (score of ≥ 5 = AUDIT-C positive).
Primary analysis
All analyses were performed on an intention-to-treat (ITT) basis using a two-sided 5% significance level. 
Analyses were performed in SAS version 9.2 (SAS Institute Inc., Cary, NC, USA).
The primary analysis compared minimal intervention with stepped care on the primary outcome measure, 
ADD, at 12 months post randomisation using a hierarchical linear model (mixed model). The mixed model 
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was used to account for any variation due to GP practice and the allocated therapist/nurse delivering the 
intervention. The analysis was adjusted for baseline ADD.
The model was developed starting from the simplest model, participants nested within GP practice, 
treating GP as a random effect. Where the data allowed, the therapist/nurse identification was added as 
random effect to make a three-level hierarchical model: participant within therapist within practice. Model 
checking was performed by assessing residual plots to ensure all models fit the data; where necessary 
transformations were employed to make the model a better fit.
The effects of missing data were examined using the commands Proc Mi and Mi Analyse in SAS v9.2. The 
same covariates that were used in the primary analysis were included. Any baseline characteristics that 
predicted missingness were also included. These analyses were used as a sensitivity analysis; the reported 
results will be those obtained from the primary analysis.
Secondary outcomes
Average drinks per day: month 6
Average drinks per day at month 6 was analysed in the same way as the primary outcome: using a mixed 
model, adjusting for baseline ADD and including GP as a random effect. Model checking was performed 
by assessing residual plots to ensure the model fit the data; where necessary, transformations or other 
analysis methods were used.
Alcohol-related problems
Alcohol-related problems measured at baseline, month 6 and month 12 were assessed using the 17-item 
DPI. The score ranges from 0 to 17, with 17 as the most severe. This was analysed in the same way as the 
primary outcome: using a mixed model, adjusting for baseline DPI and including GP as a random effect.
Alcohol Use Disorders Identification Test – Consumption (3-item) score
AUDIT-C score was measured at baseline, month 6 and month 12. The score ranges from 0 to 12, with 
12 as the most severe. This was analysed in the same way as the primary outcome: using a mixed model, 
adjusting for baseline AUDIT-C score and including GP as a random effect.
Alcohol Use Disorders Identification Test status – Consumption (3-item)
AUDIT-C status was calculated from the AUDIT-C score at baseline, month 6 and month 12. A score of 
≥ 5 is classed as AUDIT-C positive and a score of < 5 as AUDIT-C negative. A positive AUDIT-C status is 
indicative of hazardous alcohol consumption and inclusive of both harmful and dependent consumption. 
This was analysed using a mixed logistic regression model, adjusting for baseline AUDIT-C score and 
including GP as a random effect.
Quality of life
Quality of life was measured using the SF-12 questionnaire (measured at baseline and 6 and 12 months). 
The scores for the physical and mental health components were analysed using a mixed model.
Process Rating Scale
The Process Rating Scale (PRS) was adapted from the validated UKATT PRS66 and contains items 
that were used to rate structure, content and style of the delivery of the minimal and the step 1 
interventions (Appendix 10).
Hypotheses
 z Are the mean frequency and quality scores for the specific task items and practice/research nurse style 
items substantively different for the minimal intervention compared with the 20-minute behaviour 
change counselling?
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 z Is the 5-minute intervention characterised by different mean frequency ratings of MET consistent 
practice/research nurses style items (reflective listening, empathy and open questions) and 
different MET inconsistent style items (closed questions and giving unsolicited advice) from the 
20-minute intervention? 
 z Is the session content for the two treatment groups different? Should both interventions have covered 
the same session content?
 z Do specialist practice/research nurses receive different mean frequency and quality scores for specific 
task items and style items from non-specialist practice/research nurses?
 z What level of consistency is there between the ratings of the primary and secondary raters 
(inter-rater reliability)?
Analysis
The mean frequency score and the mean quality score for specific task items and practice/research nurse 
style items for each session were calculated. Linear regression models were used to compare the scores 
for the 5-minute and the 20-minute interventions. The dependent variable was mean score (frequency 
or quality) and the independent variable was session type (5- or 20-minute session). To take account 
of the clustered nature of the data, a mixed model was used with practice/research nurse fitted as a 
random effect.
The mean frequency score of MET style items and MET inconsistent items was calculated for each session. 
Linear regression models were used to compare the scores for the 5-minute (minimal) and the 20-minute 
(step 1) interventions. The dependent variable was mean frequency score and the independent variable 
was session type (5- or 20-minute session). To take account of the clustered nature of the data, a mixed 
model was used with practice or research nurse fitted as a random effect.
Session content was assessed using a series of yes/no answers to five questions. Logistic regression models 
were used for each of the five questions to test for differences between the session types. Again, a 
hierarchical model was used, with practice/research nurse fitted as a random effect.
In order to examine differences between types of practice/research nurses, the analysis for specific task 
items was repeated and the type of practice/research nurse (specialist/non-specialist) was also included in 
addition to session type.
Inter-rater reliability of the individual frequency items of the scale was examined using the intraclass 
correlation coefficient (ICC) two-way mixed-effects model (case 367) to estimate the reliability of a mean of 
several ratings.68 For four summary measures, the average of the two raters’ summary scores was plotted 
against difference in their summary score69 to make pairwise comparisons between raters. This illustrates 
graphically whether or not the summary scores are rated consistently, how well the raters agree on average 
and what the limits of agreement are.
Economic analysis
Economic evaluation of health interventions is a tool used to assist decision-makers in prioritising and 
allocating resources in the health-care sector, by assessing the value for money (cost-effectiveness) of 
alternative interventions.70
The aim of the economic evaluation was to assess the cost-effectiveness of a stepped care intervention 
compared with minimal intervention in the treatment of older hazardous alcohol users in primary care.
The first stage of the economic analysis was to calculate the cost of delivering the trial treatments. 
Opportunistic screening costs were estimated using the actual costs of screening associated with the study. 
The costs of delivering the minimal intervention and the first two tiers of stepped care were based on 
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actual patient contact time from timesheets maintained by practice or research nurses and therapists. The 
costs of the minimal intervention and the first two tiers of the stepped care programme were based on 
information gathered on patient contact with the primary care and specialist services during the trial.
The costs of the trial interventions were calculated using local costs of specialist services and included an 
allowance for the training and supervision costs, using methods developed for the UKATT trial.71 Utilisation 
of more specialist services was recorded, including the type of intervention, and costs were applied from 
previous research trials and a recent Department of Health-funded research project based on a range of 
specialist providers and intervention types.72 The incremental cost-effectiveness of stepped care compared 
with the minimal intervention was assessed from both a health and a personal social services perspective 
following National Institute for Health and Care Excellence (NICE) guidance73 and a wider public sector 
resource perspective.73 Utilisation of alcohol services outside the trial protocol, along with all other public 
sector services, including health, social welfare and contact with criminal justice agencies, was assessed 
from questionnaires administered at baseline and 6 and 12 months. Units of resource use recorded were 
multiplied by national sources of unit costs71,74 in order to provide generalisable results.
The economic analysis tested the hypothesis that stepped care is more cost-effective than the minimal 
intervention, using a cost–utility framework. Utility values were derived from the EQ-5D60 and were then 
used with population values and the quality-adjusted life-year (QALY) change calculated using the area 
under the curve method.75 Incremental cost-effectiveness analysis combined the costs of the interventions, 
as detailed above, with the QALY changes, using the cost in the intervention group over and above the 
control, divided by the incremental QALYs in the intervention group over and above the control. The non-
parametric bootstrap resampling technique was used to test the sensitivity of the calculated incremental 
cost-effectiveness ratios (ICERs) and cost-acceptability curves estimated to demonstrate different threshold 
values for a QALY.76 This would show the probability that stepped care was the preferred treatment option 
at different values for the decision-maker’s willingness to pay for a QALY.
The effects of the GP practice were analysed using a multilevel model programmed in MLwiN (MLwiN, 
Centre for Multilevel Modelling, Bristol, UK). A net benefit framework was used, estimating the benefit of 
treatment by multiplying QALY changes by a £30,000-per-QALY value net of treatment cost. This estimated 
a net benefit of treatment for each patient in the trial. The multilevel model tested the proportion of 
the variation in the net benefit of treatment attributable to the practice to investigate the effect of the 
treatment location.
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Chapter 3 Protocol changes
Outcome measures
In the original protocol the intention was to ascertain a diagnosis of alcohol use disorder using the Short 
Form-Composite International Diagnostic Interview (SF-CIDI). It was decided to replace this instrument 
with the AUDIT, with a score of ≥ 16 indicative of higher-risk alcohol use and possible alcohol dependence. 
The AUDIT has established sensitivity and specificity for the identification of at-risk alcohol use, inclusive of 
higher risk and possibly dependent alcohol use, and using this instrument reduced the response burden on 
participants. In addition, the primary outcome measure (ADD) was to be measured using a timeline follow-
back method. This method would have involved a 20- to 30-minute interview with a trained researcher 
at each of the outcome assessment points. We replaced this with a validated, reliable self-complete 
instrument: the extended AUDIT-C. Evidence exists that the timeline follow-back method acts as a brief 
intervention and as such may act to reduce the observed differences between allocated groups.77 Using 
the extended AUDIT-C reduced this measurement effect, as well as the response burden on participants. 
The original protocol had outlined our plan to conduct follow-ups face to face at 6 and 12 months post 
randomisation. As the primary outcome measure was replaced with a self-completed instrument it was 
decided to replace this follow-up method with postal follow-ups at 6 and 12 months post randomisation, 
meaning that the participants did not have to return to the practice for any follow-up assessments.
Recruitment period
The original protocol planned to recruit 500 participants over an 18-month period with all participants 
being followed up for 12 months. As the study progressed, delays to practice initiations meant that the 
study had fallen behind schedule, with the first patient not recruited until April 2008. The original end 
date for recruitment was 31 April 2009. In addition, the recruitment rate was found to be under target as 
a result of prevalence and uptake rates being lower than anticipated. This led us to apply to the funder in 
November 2008 for an 18-month extension to the recruitment period. The original sample size remained 
unchanged. The funders elected instead to track recruitment through monthly reports until the end of 
January 2010, during which time it would become clearer whether or not the target was achievable within 
an acceptable timescale. New sites and practices were brought on board (Appendix 3 details start dates of 
trial sites) and, following a successful increase in recruitment, in February 2010 an extension was approved 
allowing recruitment to continue until the end of October 2010, with the 12-month follow-up ceasing by 
the end of November 2011.
Mail-out
Owing to this lower than expected recruitment in the study, a decision was made to change the screening 
process in only one centre in order to pilot the new method. As it stood, potentially eligible patients 
were identified by opportunistic screening in their GP’s practice. That is, all patients aged ≥ 55 years who 
attended their GP’s practice was able to pick up a pack containing a screening form (AUDIT) that they 
could choose to complete (either with contact details or anonymously) regarding how much alcohol they 
consume. As the reduced recruitment rate was thought to be due to a lower prevalence rate than first 
expected, the number of patients requiring to be screened needed to be far greater than anticipated in 
order to hit the study target of 500. It was felt that the number of patients screened could be increased 
within this one new site by mailing out forms to all patients aged ≥ 55 years in the participating GP 
practice, asking them to complete the AUDIT (entirely voluntarily, and it could still be completed 
anonymously if preferred), as opposed to distributing forms only to those screened opportunistically at 
the practice.
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Therefore, a new site, Tyneside, was brought on board to pilot this method. In addition, two local 
(Tyneside) Alcohol Health Workers conducted the study in the practices and the screening form itself was 
redesigned to fit onto one side of A4 paper. The cover letter and screening form were accompanied by 
a new, coloured, z-folded patient information leaflet (Appendix 11) and a prepaid envelope allowing all 
completed questionnaires to be returned directly to the co-ordinating centre rather than handed in to the 
GP’s practice.
Following the success of this method all new practices brought on board used this mail-out method. 
Practices already taking part were given the option to switch to the mail-out method or continue with the 
current opportunistic screening process.
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Chapter 4 Clinical results
This chapter presents the statistical analysis of the AESOPS trial. In the first section of the chapter the clinical data are described, including tables and figures of data summaries. In the second section the 
statistical models fitted to the data are presented.
Trial recruitment
Eight sites participated in the study from across the UK. These were North Yorkshire and York; Hull and 
East Riding; Norfolk; Leeds; Fife; Kent; Tyneside; and County Durham. The number of participants recruited 
per site ranged from 3 to 209. Within these sites, 55 GP practices were set up, but only 53 commenced 
screening patients. Participants were recruited from 51 of the 53 practices and the number of participants 
recruited per practice ranged from 1 to 54.
Screening commenced in January 2008 and continued through to October 2010. Approximately 78,000 
screening questionnaires were distributed, with over 60,000 of these by mail-out. Twenty-five practices 
used opportunistic screening only, 28 used mail-out only and six switched from opportunistic screening 
to mail-out (as detailed in Appendix 3). The majority of screening questionnaires returned were from the 
Tyneside and Leeds sites. The first participant was recruited in April 2008 and recruitment ceased at the 
end of October 2010. The participant follow-up period ended in November 2011 after which point the 
study ended.
In total, 21,545 completed screening forms were returned. Sixteen had insufficient information to score 
the AUDIT. Of the remainder, 1625 were AUDIT positive (scored ≥ 8 on the AUDIT) (1625/21,529 = 7.5%). 
This indicates that 7.5% of the population screened were considered hazardous or harmful drinkers, a rate 
much lower than anticipated (15% to 25%). The proportion of hazardous or harmful drinkers ranged from 
6.6% to 10.4% across the sites (Table 1).
In total, there were 949 patients who were AUDIT positive and provided contact details; they had an 
average AUDIT score of 12.10 [standard deviation (SD) 5.65], which was higher than for those who were 
AUDIT positive but did not provide contact details (Table 2).
The percentage of eligible patients (i.e. AUDIT positive with contact details provided) who were deemed 
fully eligible [928/1626 = 57% (i.e. 949 AUDIT positive, but 21 failed one or more of the other eligibility 
criteria)] and went on to be randomised was only 57% (529/928 = 57%).
Figure 1, the Consolidated Standards of Reporting Trials (CONSORT) flowchart, shows the progress of 
participants through the trial.
Clinical data
In total, 529 participants were randomised: 266 to stepped care and 263 to minimal intervention. A 
baseline questionnaire was not received from seven participants following completion: three from the 
stepped care group and four from the minimal group.
The majority of participants were male (n = 425; 80%) and the average age was 63 years (range 
55–85 years) (Table 3). A score of ≥ 20 on the AUDIT indicates possible alcohol dependence. Overall, 
7.9% of those randomised obtained a score of ≥ 20 at screening. This was higher in the minimal group 
(9.5%) than in the stepped care group (6.4%). This is summarised in Table 4. The average AUDIT-C score 
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was 8.3 (SD 2.2) and ADD was 3.39 (SD 2.2). The baseline characteristics are summarised by treatment 
group (Tables 5 and 6).
Comparing the trial participants with those screened, there were more males (80% compared with 
45% in the screened population) and participants were slightly younger: 63 years compared with 
68 years (Table 3).
Baseline data were collected on those who were willing to participate but were not eligible for the trial 
(non-participants) because they were AUDIT negative at screening. In order to compare the baseline 
characteristics of participants and non-participants, the AUDIT-C was also calculated for the screening 
sample. Comparing non-participants with trial participants, trial participants were younger and more likely 
to be male.
Analysis of clinical results
This portion of the report presents the results of the statistical models fitted to the data. It is arranged into 
three main sections. The first section presents the results of the modelling of the primary outcome: ADD 
at 12 months. The second section presents the results of the modelling of the secondary outcomes: ADD 
(derived from the extended AUDIT-C) at 6 months; alcohol-related problems assessed using the DPI at 6 
and 12 months; extended AUDIT-C score at 6 and 12 months; and HRQoL at 6 and 12 months. The third 
section summarises the conclusions of the statistical analysis of the clinical outcomes.
TABLE 1 Proportion of hazardous or harmful drinkers across study sites
Site N; number audit positive, n (%)
York 2360; 195 (8.3)
Hull 691; 72 (10.4)
Norfolk 2522; 166 (6.6)
Leeds 6629; 466 (7.0)
Kent 237; 20 (8.4)
Fife 790; 63 (8.0)
Tyneside 5877; 483 (8.2)
County Durham 2423; 160 (6.6)
Total 21,529; 1625 (7.5)
TABLE 2 The AUDIT score at screening 
Statistic
Positive audit
No Yes
TotalIdentifiable Anonymous Identifiable Anonymous
n 11,210 8694 949 676 21,529
Mean (SD) 2.21 (1.90) 2.26 (1.88) 12.10 (5.65) 11.11 (4.45) 2.95 (3.40)
Median (min., max.) 2 (0, 7) 2 (0, 7) 10 (8, 40) 10 (8, 40) 2 (0, 40)
max., maximum; min., minimum.
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Followed up at month 12
[n = 232/263 (88.2%)]
Randomised
(n = 529)
Screened
(n = 21,545)
Eligible
(positive with contact details)
(n = 949)
Negative n =  19,904
Positive but anonymous n = 676
Insufficient information to score n = 16
Not interested/refused
appointment/no contact n = 384
Not eligible n = 21
Refused consent n = 12
3 × DNA n = 3  
Minimal intervention
(n = 263)
Stepped care
(n = 266)
Received minimal intervention
(n = 262)
Received step 1 (n = 265)
Followed up at month 6
[n = 234/263 (89%)]
Followed up at month 6
[n = 240/266 (90.2%)]
Followed up at month 12
[n = 231/266 (86.8%)]
Not requiring referral to step 2 (n = 108)
Full withdrawal n =1
(patient randomised
in error)
Withdrawal
from/lost to
follow-up (n = 7)
Withdrawal from/
lost to follow-up
(n = 6)
Referred onto step 2
Attended one MET session
Attended two MET sessions
Attended all three MET sessions
n = 146
n = 11
n = 15
n = 15
Eligible for referral onto step 3 (n = 21)
Full withdrawal n =1
(patient withdrew consent after
randomisation/before treatment)
Required telephone assessment
for step 2 (n = 264)
Assessed for step 2 (n = 254)
Unable to contact (n = 10)
Full withdrawal  n = 4
Withdrew from treatment before
attending any sessions  n = 19
Unable to contact  n = 11
Refused appointment/no sessions ever
attended  n = 71
Withdrew from treatment (n = 1)
Required telephone assessment
for step 3 (n = 40)Unable to contact (n = 10)
Assessed for step 3 (n = 30)Not requiring referral to step 3 (n = 9)
Refused referral n = 10
Not known if referred n = 3
Referred n = 8
(outcome unknown n = 2;
dropped out n = 1;
completed treatment n = 5)
Withdrew from treatment after one session (n = 1)
FIGURE 1 The AESOPS CONSORT diagram.
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TABLE 3 Characteristics of participants and non-participants
Characteristics Screened (n = 21,545)
Non-participants 
(n = 4231)
Trial participants 
(n = 529)
Sex
Male (%) 45.3 44.7 80.3
Age (years)
Mean (SD) 68 (8.6) 67 (7.9) 63 (5.8)
Median (min., max.) 66 (55, 105) 66 (55, 105) 62 (55, 85)
AUDIT-C score
Mean (SD) 2.6 (2.4) 2.5 (2.0) 8.3 (2.2)
Median (min., max.) 2 (0, 12) 2 (0, 12) 8 (0, 12)
ADD
Mean (SD) NA 0.51 (0.76) 3.39 (2.21)
Median (min., max.) NA 0.15 (0, 8.57) 3 (0, 8.57)
max., maximum; min., minimum; NA, not applicable.
TABLE 4 Numbers randomised in each treatment arm with AUDIT score ≥ 20 at screening
Treatment arm
Screening AUDIT score ≥ 20
No Yes Total
Stepped care, n (%) 249 (93.6) 17 (6.4) 266 (100)
Minimal, n (%) 238 (90.5) 25 (9.5) 263 (100)
Overall, n (%) 487 (92.1) 42 (7.9) 529 (100)
TABLE 5 Baseline patient characteristics
Characteristics Stepped care (N = 266) Minimal (N = 263) Total (N = 529)
Sex, N 266 263 529
Male, n (%) 220 (82.7) 205 (77.9) 425 (80.3)
Female, n (%) 46 (17.3) 58 (22.1) 104 (19.7)
Age (years), n 266 263 529
Mean (SD) 62.92 (5.82) 62.74 (5.86) 62.83 (5.83)
Median (min., max.) 62 (55, 83) 62 (55, 85) 62.00 (55, 85)
Smoking status, N 256 251 507
Never smoked, n (%) 71 (27.7) 80 (31.9) 151 (29.8)
Ex-smoker, n (%) 141 (55.1) 125 (49.8) 266 (52.5)
Current smoker, n (%) 44 (17.2) 46 (18.3) 90 (17.7)
Employment, N 258 258 516
In employment or self-employment, n (%) 89 (34.5) 93 (36.0) 182 (35.3)
Retired, n (%) 138 (53.5) 132 (51.2) 270 (52.3)
Housework, n (%) 4 (1.5) 3 (1.2) 7 (1.4)
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Characteristics Stepped care (N = 266) Minimal (N = 263) Total (N = 529)
Student, n (%) 1 (0.4) 0 (0.0) 1 (0.2)
Seeking work, n (%) 9 (3.5) 5 (1.9) 14 (2.7)
Other, n (%) 17 (6.6) 25 (9.7) 42 (8.1)
Living arrangements, N 263 257 520
Single, n (%) 61 (23.2) 59 (23.0) 120 (23.1)
Married, n (%) 166 (63.1) 155 (60.3) 321 (61.7)
Cohabiting, n (%) 22 (8.4) 17 (6.6) 39 (7.5)
Widowed, n (%) 14 (5.3) 26 (10.1) 40 (7.7)
Accommodation, N 263 257 520
Owner occupied, n (%) 211 (80.2) 202 (78.6) 413 (79.4)
Private rented, n (%) 14 (5.3) 14 (5.4) 28 (5.4)
Local authority/housing association, n (%) 37 (14.1) 40 (15.6) 77 (14.8)
Temporary, n (%) 1 (0.4) 1 (0.4) 2 (0.4)
Education continued after school, N 262 258 520
Yes, n (%) 171 (65.3) 158 (61.2) 329 (63.3)
No, n (%) 91 (34.7) 100 (38.8) 191 (36.7)
Degree or equivalent professional 
qualification, N
261 256 517
Yes, n (%) 116 (44.4) 100 (39.1) 216 (41.8)
No, n (%) 145 (55.6) 156 (60.9) 301 (58.2)
max., maximum; min., minimum.
TABLE 6 Baseline outcome measures
Outcome measure Stepped care (N = 266) Minimal (N = 263) Total (N = 529)
ADD, n 263 255 518
Mean (SD) 3.38 (2.24) 3.41 (2.19) 3.39 (2.21)
Median (min., max.) 3 (0, 8.57) 3 (0, 8.57) 3 (0, 8.57)
DPI, n 262 257 519
Mean (SD) 2.64 (2.90) 3.08 (3.33) 2.86 (3.12)
Median (min., max.) 2 (0, 15) 2 (0, 15.87) 2 (0, 15.87)
SF-12 PCS, n 260 256 516
Mean (SD) 47.67 (11.21) 47.33 (10.99) 47.50 (11.09)
Median (min., max.) 52.00 (10.04, 70.37) 49.81 (7.87, 67.17) 51.02 (7.87, 70.37)
SF-12 MCS, n 260 256 516
Mean (SD) 51.85 (9.51) 50.18 (10.71) 51.02 (10.15)
Median (min., max.) 55.06 (9.13, 66.33) 52.79 (6.98, 71.21) 54.37 (6.98, 71.21)
continued
TABLE 5 Baseline patient characteristics (continued)
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Outcome measure Stepped care (N = 266) Minimal (N = 263) Total (N = 529)
AUDIT-C score, n 263 259 522
Mean (SD) 8.26 (2.19) 8.25 (2.26) 8.26 (2.22)
Median (min., max.) 8 (3, 12) 8 (0, 12) 8 (0, 12)
AUDIT-C status, N 263 259 522
Negative, n (%) 13 (4.9) 15 (5.8) 28 (5.4)
Positive, n (%) 250 (95.1) 244 (94.2) 494 (94.6)
max., maximum; MCS, mental component score; min., minimum; PCS, physical component score.
Primary outcome
Overall, the mean ADD score in both groups decreased from baseline at both month 6 and month 
12. At month 6 the stepped care group had a lower ADD but at month 12 the minimal intervention 
group had the lower ADD. This is summarised in Table 7. Figure 2 shows the mean ADD scores for the 
complete cases.
A mixed model was used to compare ADD between the two randomised groups. The baseline value 
of ADD was included as a covariate and a variable was also included for treatment group; these were 
included as fixed effects. To account for the variation due to GP practice, this was included as a random 
effect in the model. Expanding the model to a three-level model to include nurse/therapist resulted in a 
model that failed to converge, and so the final model used was a two-level mixed model with participants 
nested within GP practice.
The ADD had a skewed distribution; a transformation improved the model fit. A log-transformation was 
used in the final model so the dependent variable was Ln(ADD_M12 +1) (M12 = month 12).
In total, 456 participants had a response at month 12; however, in seven, ADD value at baseline was 
missing, and so these participants were not included in the primary analysis. The GP random effect was 
not significant, indicating that transformed ADD did not vary significantly between centres. There were no 
significant differences in ADD between the treatment groups at month 12. The stepped care group had 
a marginally higher ADD than the minimal intervention group but not significantly so. The results of the 
analysis are seen in Table 8.
Transforming the data for the analysis was necessary because of the skewed distribution. As the 
transformation included the addition of 1, this meant that a back-transformation was more problematic; 
however, it was anticipated that this would not have a great influence on the back-transformed estimate. 
To verify this, an additional analysis, excluding those with an ADD of zero, was used to confirm the 
result. In order to summarise the results in a more meaningful way, the estimate of the difference was 
anti-logged. It was found that ADD at month 12 for the stepped care group was 1.025 [95% confidence 
interval (CI) 0.94 to 1.12] times that of the minimal group. The analysis excluding those with ADD of zero, 
carried out to check that the log(ADD + 1) produced a good approximation, produced very similar results, 
and so we concluded that these estimates were acceptable.
Missing data
The overall follow-up rate at month 12 was 87.5%, with 86.8% followed up in the stepped care group 
and 88.2% in the minimal intervention group. Those followed up were slightly older, more likely to be 
male and had a slightly lower ADD at baseline. The results are summarised in Table 9.
TABLE 6 Baseline outcome measures (continued)
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TABLE 7 Summary of ADD 
Follow-up 
Treatment arm
Stepped care Minimal Total
Baseline
Valid n 263 255 518
Mean (SD) 3.38 (2.24) 3.41 (2.19) 3.39 (2.21)
Median (min., max.) 3.00 (0, 8.57) 3.00 (0, 8.57) 3.00 (0, 8.57)
Month 6
Valid n 236 229 465
Mean (SD) 2.45 (1.85) 2.81 (2.03) 2.63 (1.95)
Median (min., max.) 1.96 (0, 8.57) 2.25 (0, 8.57) 2.25 (0, 8.57)
Month 12
Valid n 228 228 456
Mean (SD) 2.56 (2.09) 2.49 (1.93) 2.53 (2.01)
Median (min., max.) 1.96 (0, 8.57) 2.25 (0, 8.57) 2.11 (0, 8.57)
max., maximum; min., minimum.
TABLE 8 Estimates of ADD (Ln-transformed)
Follow-up
Stepped care estimate 
(SD) (n = 226)
Minimal estimate (SD)
(n = 223) Difference (95% CI) p-value
Month 12 1.129 (0.037) 1.104 (0.037) 0.025 (–0.062 to 0.112) 0.575
Covariance parameter estimates Estimate (SE) p-value
Random GP effect 0.013 (0.009) 0.059
Measurement error 0.215 (0.015) < 0.001
SE, standard error.
The multiple imputation commands in SAS, SAS Proc MI and MI Analyse were used to perform multiple 
imputations in order to take into account the missing data in the analysis. Multiple imputation78 replaces 
each missing value with a range of possible values. Proc MI produces these imputed data sets and MI 
Analyse allows the results from these datasets to be combined and analysed using standard procedures. 
The results can be seen in Table 10. The estimates from the multiple imputation are similar to the results 
from the primary analysis.
Analysis of secondary outcomes
In this section, the results of the secondary analysis are presented.
Average drinks per day at month 6
The ADD at month 6 was analysed in the same way as the primary outcomes: using a mixed model, 
adjusting for baseline ADD and including GP as a random effect. The ADD had a skewed distribution; 
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TABLE 9 Characteristics of those followed up
Characteristics
Month 12 follow-up?
No Yes Total
Stepped care, n (%) 35 (13.2) 231 (86.8) 263 (100)
Minimal, n (%) 31 (11.8) 232 (88.2) 266 (100)
Overall, n (%) 66 (12.5) 463 (87.5) 529 (100)
Age (years), n 66 463 529
Mean (SD) 61.50 (5.01) 63.02 (5.92) 62.83 (5.83)
Median (min., max.) 61.5 (55, 75) 62 (55, 85) 62 (55, 85)
ADD, n 62 456 518
Mean (SD) 3.82 (2.62) 3.34 (2.15) 3.39 (2.21)
Median (min., max.) 3.27 (0.35, 8.57) 3 (0, 8.57) 3 (0, 8.57)
Sex, N 66 463 529
Male, n (%) 50 (11.8) 375 (88.2) 425 (100)
Female, n (%) 16 (15.4) 88 (84.6) 104 (100)
max., maximum; min., minimum.
TABLE 10 Missing data analysis
Follow-up
Primary analysis Multiple imputation
Difference (95% CI) (n = 449) p-value Difference (95% CI) (n = 525) p-value
Month 12 0.025 (–0.062 to 0.112) 0.575 0.033 (–0.065 to 0.131) 0.470
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FIGURE 2 Average drinks per day (complete cases).
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a transformation improved the model fit. A log transformation was used in the final model so the 
dependent variable was Ln(ADD_M6 + 1) (Table 11).
At month 6, the stepped care group had a lower ADD then the minimal intervention group. This was not 
significant at the 5% level.
The AUDIT-C score was analysed in a similar way to the primary outcomes: using a mixed model, adjusting 
for baseline AUDIT-C score and including GP as a random effect. There were no significant differences in 
AUDIT-C score between the treatment groups at month 6 or month 12. The minimal intervention had a 
marginally higher AUDIT-C score at month 6, but a lower score at month 12; however, neither difference 
was significant (Tables 12 and 13).
The AUDIT-C status was analysed using a hierarchical logistic regression model, adjusting from baseline 
status with GP practice treated as a random effect. The outcome was AUDIT-C positive. At month 6, the 
adjusted analysis found no significant difference in AUDIT-C status between the two treatment groups. At 
month 6, the stepped care group had a larger proportion of AUDIT-C positives but a smaller proportion at 
month 12 compared with the minimal intervention. The results can be seen in Tables 14 and 15.
Drinking Problems Index
The DPI at month 6 and month 12 was analysed using a mixed model, adjusting for baseline DPI and 
including GP as a random effect. DPI scores had skewed distributions, so a log transformation was used 
TABLE 11 Estimates of ADD (transformed): month 6
Follow-up
Stepped care estimate (SD) 
(n = 234)
Minimal estimate (SD) 
(n = 230) Difference (95% CI) p-value
Month 6 1.119 (0.034) 1.192 (0.034) –0.073 (–0.156 to 
0.011)
0.088
TABLE 12 The AUDIT-C scores 
Follow-up
Intervention arm
Stepped care Minimal Total
Baseline
n 263 259 522
Mean (SD) 8.26 (2.19) 8.25 (2.26) 8.26 (2.22)
Median (min., max.) 8 (3, 12) 8.00 (0, 12) 8 (0, 12)
Month 6
n 238 231 469
Mean (SD) 7.02 (2.48) 7.38 (2.55) 7.20 (2.52)
Median (min., max.) 7 (0, 12) 8.00 (0, 12) 7.00 (0, 12)
Month 12
n 229 229 458
Mean (SD) 7.07 (2.48) 6.96 (2.66) 7.02 (2.57)
Median (min., max.) 7 (0,12) 7 (0, 12) 7 (0, 12)
max., maximum; min., minimum.
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which improved the model fit. As the DPI range included zero, one (1) was added to the total DPI score to 
enable logs to be calculated (Tables 16 and 17).
At month 6 and month 12, the stepped care group had a lower DPI score than the minimal intervention 
group. This was not significant at the 5% level.
Quality of life using the Short Form Questionnaire-12 items
The hierarchical model failed to converge so results from a simple linear regression model are presented 
(Tables 18 and 19).
At month 6 and month 12, the stepped care group had a lower mental component score (MCS) than the 
minimal intervention group. The stepped care group also had lower physical component score (PCS) at 
month 6 and month 12. These differences were not significant at the 5% level.
TABLE 13 The AUDIT-C estimates 
Follow-up
Stepped care estimates 
(SD)
Minimal estimates 
(SD) Difference (95% CI) p-value
Month 6 7.085 (0.159) (n = 236) 7.373 (0.160)  (n = 228) –0.288 (–0.687 to 0.111) 0.156
Month 12 7.116 (0.166)  (n = 227) 6.957 (0.166) (n = 226) 0.160 (–0.250 to 0.569) 0.445
TABLE 14 The AUDIT-C status 
Follow-up Stepped care Minimal Total
Baseline, N 263 259 522
AUDIT-C negative, n (%) 13 (4.9) 15 (5.8) 28 (5.4)
AUDIT-C positive, n (%) 250 (95.1) 244 (94.2) 494 (94.6)
Month 6, N 238 231 469
AUDIT-C negative, n (%) 35 (14.7) 26 (11.3) 61 (13.0)
AUDIT-C positive, n (%) 203 (85.3) 205 (88.7) 408 (87.0)
Month 12, N 229 229 458
AUDIT-C negative, n (%) 35 (15.3) 41 (17.9) 76 (16.6)
AUDIT-C positive, n (%) 194 (84.7) 188 (82.1) 382 (83.4)
TABLE 15 The AUDIT–C status: number AUDIT positive
Follow-up Stepped care Minimal Odds ratio (95% CI) p-value
Month 6 0.81 (0.48 to 1.37) 0.427
N 236 228
n (%) 193 (82) 186 (82)
Month 12 1.37 (0.76 to 2.47) 0.289
N 227 226
n (%) 202 (89) 202 (89)
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Treatment uptake by the stepped care group
In total, 146 participants were referred to step 2; of these, 41 (28%) went on to receive step 2. The other 
105 participants (72%) either declined or could not be contacted. Although those who attended step 2 
had a higher average ADD than those who did not attend, it was not significantly higher (Table 20).
TABLE 16 The DPI scores 
Follow-up Stepped care Minimal Total
Baseline
n 262 257 519
Mean (SD) 2.64 (2.90) 3.08 (3.33) 2.86 (3.12)
Median (min., max.) 2.00 (0, 15) 2.00 (0, 15.87) 2.00 (0, 15.87)
Month 6
n 238 233 471
Mean (SD) 1.79 (2.60) 2.41 (3.22) 2.10 (2.93)
Median (min., max.) 1.00 (0, 16) 1.00 (0, 17) 1.00 (0, 17)
Month 12
n 229 230 459
Mean (SD) 1.90 (3.03) 2.25 (3.04) 2.07 (3.04)
Median (min., max.) 1.00 (0, 17) 1.00 (0, 16) 1.00 (0, 17)
max., maximum; min., minimum.
TABLE 17 Estimates of DPI scores (transformed)
Follow-up
Stepped care estimate 
(SD) Minimal estimate (SD) Difference (95% CI) p-value
Month 6 n = 236
0.799 (0.040)
n = 229
0.864 (0.040)
–0.064 (–0.173 to 0.045) 0.247
Month 12 n = 227
0.783 (0.038)
n = 225
0.802 (0.038)
–0.018 (–0.125 to 0.088) 0.735
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TABLE 18 The SF-12 quality-of-life scores 
Component score Stepped care Minimal Total
PCS
Baseline
n 260 256 516
Mean (SD) 47.67 (11.21) 47.33 (10.99) 47.50 (11.09)
Median (min., max.) 52 (10.04, 70.37) 49.81 (7.87, 67.17) 51.02 (7.87, 70.37)
Month 6
n 237 233 470
Mean (SD) 47.35 (11.33) 47.74 (11.16) 47.54 (11.24)
Median (min., max.) 51.46 (7.02, 66.45) 50.66 (11.38, 68.68) 51.22 (7.02, 68.68)
Month 12
n 228 228 456
Mean (SD) 47.24 (11.87) 47.48 (10.99) 47.36 (11.42)
Median (min., max.) 51.59 (12.69, 65.02) 51.02 (14.37, 68.20) 51.28 (12.69, 68.20)
MCS
Baseline
n 260 256 516
Mean (SD) 51.85 (9.51) 50.18 (10.71) 51.02 (10.15)
Median (min., max.) 55.06 (9.13, 66.33) 52.79 (6.98, 71.21) 54.37 (6.98, 71.21)
Month 6
n 237 233 470
Mean (SD) 51.77 (9.80) 50.48 (10.61) 51.13 (10.22)
Median (min., max.) 54.96 (11.20, 64.40) 54.34 (12.55, 67.52) 54.66 (11.20, 67.52)
Month 12
n 228 228 456
Mean (SD) 51.95 (9.72) 51.53 (9.85) 51.74 (9.78)
Median (min., max.) 55.21 (3.58, 64.74) 54.37 (12.50, 73.02) 54.77 (3.58, 73.02)
max., maximum; MCS, mental component score; min., minimum; PCS, physical component score.
TABLE 19 The SF-12 quality-of-life estimates 
Component score Stepped care estimate (SD) Minimal estimate (SD) Difference (95% CI) p-value
MCS
Month 6 51.214 (0.443) (n = 234) 51.302 (0.448) (n = 228) –0.088 (–1.329 to 1.153) 0.889
Month 12 51.630 (0.462) (n = 224) 52.108 (0.463) (n = 22) –0.478 (–0.809 to 1.766) 0.466
PCS
Month 6 47.152 (0.423) (n = 234) 47.873 (0.429) (n = 228) –0.722 (–1.905 to 0.462) 0.232
Month 12 47.069 (0.489) (n = 224) 47.707 (0.490) (n = 223) –0.637 (–1.998 to 0.723) 0.692
MCS, mental component score; PCS, physical component score.
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Summary
There was no evidence of a difference in ADD when comparing the stepped care group with the minimal 
intervention group at month 12.
There was no evidence of a difference in any of the secondary outcome measures (AUDIT score, alcohol-
related problems and quality of life) at either month 6 or month 12.
TABLE 20 Average ADD scores: step 2 non-attendees vs attendees 
Outcome Non-attendees (n = 105) Attendees (n = 41) Difference (95% CI) p-value
ADD score 3.91 (2.13) 4.24 (2.18) 0.33 (–0.45 to 1.12) 0.401
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Chapter 5 Economic analysis
Brief interventions have been proven to be both clinically effective and cost-effective in the management of individuals with hazardous and harmful drinking in primary care settings.27–29,79 Cost-effectiveness 
for all adult drinkers for such interventions has partly been driven by reductions in health service costs of 
alcohol harm. The estimated wider costs of alcohol-use disorders, in terms of health care, crime, family 
problems and loss of productivity, was up to £258 per year in 2008.80 Existing studies, however, have 
included few older drinkers, and this population may have different alcohol problems and consequently 
different health and social costs.
The economic analysis tests the hypothesis that a stepped care intervention is more cost-effective 
for older hazardous alcohol users in primary care when compared with a 5-minute brief intervention 
(minimal intervention).
The objectives of the economic analysis are to:
1. compare costs associated with the stepped care and minimal interventions at 6 and 12 months 
post randomisation
2. estimate the health benefits, measured using QALYs, from the interventions
3. assess the cost-effectiveness of the stepped care intervention compared with the minimal intervention.
Data were analysed according to the ITT principle, whereby all participants were analysed as members of 
their allocated group irrespective of the intervention received. Following technology appraisal guidelines 
used by NICE, the analysis was performed from the NHS/Personal Social Services perspective. All costs were 
estimated for the year 2009–10 in UK pounds (£). Follow-up was at 6 and 12 months from randomisation.
Assessment of costs
A micro-costing approach was used to compute the costs of trial interventions. The estimation of costs 
involved three distinct phases: identifying the relevant resource-items; measuring the use of the identified 
resource-items; and assigning unit costs or prices to them.
Attendees at primary care aged ≥ 55 years were screened to determine if they were eligible for the trial 
interventions. Opportunistic screening costs were estimated from the actual resource use associated with 
the screening process, which consisted of an information letter, a copy of the AUDIT questionnaire and the 
time input of the practice/research nurse or practitioner who contacted screen-positive patients.
The costs of the minimal intervention and the first two tiers of the stepped care programme (step 1 and 
step 2) were based on information gathered on patient contact with the primary care and specialist 
services during the trial.
Participants in the control arm received a 5-minute discussion with a practice/research nurse about 
the health consequences of continued hazardous alcohol consumption, and a brief self-help leaflet. 
Therefore, the cost of minimal intervention included practice/research nurse time and material costs of the 
self-help leaflet.
The costs of stepped interventions were calculated using local costs of specialist services and included an 
allowance for training and supervision costs. For steps 1 and 2 of the intervention, therapists were invited 
to participate in training sessions to provide them with skills for delivering BCC (step 1) and MET (step 2). 
The cost component for training included the time that trainers and therapists spent in training and 
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supervision, plus use of space and materials. The total cost for training in each stage was allocated to the 
number of sessions delivered for the trial.
Step 1 of the intervention included a 20-minute session of BCC by a practice/research nurse. Step 2 
consisted of three 40-minute sessions of MET on a weekly basis delivered by a therapist such as an alcohol 
health worker, clinical nurse manager or drug and alcohol counsellor. The actual time therapists spent 
delivering each intervention session was recorded and used to compute actual intervention costs by 
multiplying by their individual salaries.
Four weeks after each step, participants were contacted by telephone by a practice/research nurse for a 
reassessment of their alcohol consumption. These costs were calculated based on an average 5 minutes of 
practice/research nurse time and the costs of the line rental.
Step 3 of the stepped care intervention was a referral to local specialist alcohol services to receive specialist 
intervention. The resource use of this step was not specified in the trial and could encompass a variety of 
intervention approaches; interventions in this step could expand beyond the time horizon of the trial and a 
standard cost of £811 per patient was assumed according to the literature.81
Data on additional utilisation of health and social care and criminal justice services outside the trial 
protocol were collected from questionnaires administered at baseline, 6 months and 12 months. At each 
time point, participants were asked about their resource use over the previous 6 months. Units of resource 
use recorded were then multiplied by national sources of unit costs81 in order to provide generalisable 
results. Table 21 presents a summary of the categories of resource use together with their unit costs.
Assessment of outcome
The economic evaluation used QALYs as recommended by NICE as a measure of health benefit for their 
reference case.73 QALYs were derived from utility scores measured by EQ-5D questionnaires at baseline 
and at 6-month and 12-month follow-up. The EQ-5D is a standardised instrument for use as a measure 
of health outcomes developed by the EuroQol Group.60 The EQ-5D results were scored using the UK York 
time trade-off tariff obtained from a sample of around 3000 members of the general UK population.83,84 
Given the assumption that health status changes between measurements are smooth and gradual over 
time, utility scores were converted into QALYs using the area under the curve method.85
To appropriately adjust potential imbalances and ensure comparability with the clinical analysis, multiple 
regression methods were applied to give the differential mean QALYs and the prediction of adjusted QALYs 
by controlling for baseline EQ-5D scores.86,87
Assessment of cost-effectiveness
Incremental cost-effectiveness analysis was performed to combine the costs of the interventions with 
health outcomes. The mean difference in costs between the two trial groups was compared with mean 
difference in effectiveness to generate ICERs.70
ICER SC MI
SC MI
= =
−
−
∆
∆
C
E
C C
E E
 (1)
Here, E represents the change in effects (in this case measured QALYs), and C represents the costs of 
intervention, measured in monetary units, while subscripts ‘SC’ and ‘MI’ refer to stepped care and minimal 
intervention, respectively.
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Handling uncertainty
Cost and QALY data are typically not normally distributed. Cost data are often highly right skewed because 
of a few cases that incur extremely high costs, while QALY data are normally left skewed because of the 
ceiling effect.88–90 In this study, the non-parametric bootstrap technique was employed to explore the 
sensitivity of calculated ICERs. Bootstrapping is a resampling method that generates multiple replications 
of the statistic of interest (ICER) by sampling with replacement from the original data.91 The bootstrap 
method is preferable for skewed data as it does not rely on parametric assumptions concerning the 
underlying distribution of data.92,93
The results from the bootstrap resampling were used to plot cost-effectiveness planes (CEPs) and cost-
effectiveness acceptability curves (CEACs) to show the decision uncertainty surrounding adoption decisions. 
The CEACs present the probability that stepped care is the preferred treatment option at different values 
for a decision-maker’s willingness to pay (WTP) for a QALY.94
Sensitivity analysis
Sensitivity analysis is an appropriate way to check on methodological uncertainty. In this study, sensitivity 
analysis was planned to vary assumptions about costing methods. It was found that the distributional 
problem that arose for cost data was mainly attributable to a few ‘extreme values’ in the distribution. 
TABLE 21 Summary of main resources and unit costs in 2009–10 prices
Resource item Unit cost (£) Source
A&E visit 37 Curtis81
Inpatient night 240 Curtis81
Outpatient attendance 152 Curtis81
Day case 637 Curtis81
Emergency ambulance 277.80 Curtis81
Patient transport service 57.02 Curtis81
GP (surgery) 32 Curtis81
GP (home) 106 Curtis81
Practice nurse (surgery) 10 Curtis81
Practice nurse (home) 13 Curtis81
Prescription 8.8 Curtis81
Day centres 36 per day Curtis81
Meals on wheels 2.86 per meal Oddie82
Social services home care services 92 per day Curtis81
Social worker (office) (30 minutes) 26.50 Curtis81
Social worker (home) (60 minutes) 53 Curtis81
Care worker (office) (30 minutes) 25 Curtis81
Care worker (home) (60 minutes) 50 Curtis81
A&E, accident and emergency.
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Therefore, extreme values, defined as those deviating by five times the standard deviation, were excluded 
and the incremental cost-effectiveness analysis was repeated in the sensitivity analysis.
Results of economic analysis
A total of 21,546 primary care attendees aged ≥ 55 years were screened using the AUDIT questionnaire. A 
total of 529 hazardous alcohol drinkers were recruited to the trial and received either minimal or stepped 
care interventions.
The base-case cost-effectiveness analysis was based on 422 participants (212 in the stepped care group 
and 210 in the minimal intervention group) with both completed cost and outcome estimates for three 
different time points, i.e. baseline, 6-month and 12-month follow-up.
Costs
The breakdown of screening costs and intervention costs by allocated treatment is summarised in Table 22. 
The opportunistic screening costs consisted of the costs of materials provided to the 21,546 screened 
patients and the cost of 5 minutes of practice/research nurse time to contact screen-positive patients. The 
mean screening cost for every participant recruited into the trial was £5.52; this part of the cost was equal 
in both intervention and control groups.
The average cost of minimal intervention was £2.34 per participant. This included £2.17 cost of practice/
research nurse time and £0.17 cost of the self-help material.
For participants assigned to the stepped care group, a 20-minute BCC session together with a self-
help booklet was provided for step 1 of the intervention. The intervention cost for this step was £8.89 
per participant.
Step 2 consisted of three sessions of MET. Full data were available for 33 of the participants who received 
at least one session of therapy, averaging out at a cost of £36.84 per patient, calculated using the actual 
amount of therapist contact time for each patient. As part of the intervention, a practice/research nurse 
contacted participants and a short telephone assessment was made to reassess alcohol consumption after 
each step. The average reassessment cost was £2.42 per patient. The trial data show that attendance 
at the third stage was actually quite rare. Only five patients completed specialist interventions, with an 
average cost of £811 per person.
Table 23 presents the quantity of health and social care and criminal justice service utilisations at baseline 
and 6 months and 12 months after randomisation for both trial groups. No police and criminal justice 
system contacts were reported by participants.
In addition to the costs of delivering the stepped care interventions, a unit training cost per session was 
added to the intervention cost to estimate a total cost for stepped care. The training costs for BCC (step 1) 
and MET (step 2) were £3.69 and £12.71 per session, respectively. The overall average cost of treatment 
for the intervention group was therefore £46.63 (SD £146) per trial participant (Table 24).
Costs of resource use were calculated by multiplying the product of each resource-use category by its 
associated unit cost listed in Table 21. Total costs for each group were reported in the table by adding up 
resource use costs, screening costs and intervention costs (see Table 24). The results showed that resource 
use costs were the biggest contributor to the overall costs for both groups.
The mean total cost per participant in the stepped care group was £496 (SD £844) compared with £475 
(SD £903) in the minimal intervention group at the 6-month follow-up. Using a 12-month time horizon, 
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the mean total cost was £906 (SD £1369) and £1077 (SD £2636) in the stepped care and minimal groups, 
respectively.
The costs of health and social care resource use were higher in the stepped care group at baseline 
(difference £54; 95% CI –£140 to £248). This indicates some baseline imbalance in cost estimates, so 
we adjusted total costs by controlling for the imbalance in baseline resource use using the multiple 
regression method.
The adjusted 6-month cost for the stepped care group was £488 compared with £482 for the minimal 
intervention group, giving a difference of –£6.38 (95% CI –£164 to £151). At the 12-month follow-up, 
the adjusted mean cost was £875 in the stepped care group compared with £1089 in the minimal group 
(difference –£194; 95% CI –£585 to £198). The results indicated that stepped care was, on average, 
less costly compared with minimal intervention at 12-month follow-up, although the difference is not 
statistically significant.
Outcomes
Mean EQ-5D scores are reported for both groups at the baseline, 6-month and 12-month post 
randomisations. Figure 3 presents the change of mean EQ-5D scores over time.
TABLE 22 Screening and intervention costs (£ in 2010 prices) by allocated treatment 
Source of cost Intervention group Control group
Opportunistic screening cost 
Information letter and AUDIT questionnaire 1.63 per participant recruited 1.63 per participant recruited 
Five minutes of practice/research nurse contact 
time with screen-positive patients
3.89 per participant recruited 3.89 per participant recruited
Minimal intervention
Five minutes of practice/research nurse time 0.00 2.17 per participant
Self-help bookleta 0.00 0.17 per participant
Stepped care intervention
Step 1: BCC
Training cost for practice/research nurses 3.69 per session 0.00
Twenty-minute BCC 8.72 (SD 0.62) per session 0.00
Self-help bookleta 0.17 per participant 0.00
Short telephone assessment 4 weeks afterb 2.42 per participant 0.00
Step 2: MET
Training cost for therapists 12.71 per session 0.00
Three 40-minute sessions with trained alcohol 
therapist
36.84 (SD 52.34) per participant 0.00
Short telephone assessment 4 weeks after 2.42 per participant 0.00
Step 3: specialist alcohol services
811 per patient 0.00
a ‘Safer drinking – a self help guide’. 
b Telephone calls at 5p per minute local calls (includes line rental).95
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Figure 3 shows that, in both the intervention and control groups, mean EQ-5D scores at 6 months were 
lower than at baseline, while at the end of the 12-month follow-up, the scores increased and were higher 
than the baseline utilities. Changes in EQ-5D scores were transformed to estimate the QALY gains for 
each patient (Table 25). The mean unadjusted difference QALY gain over the 6 months from baseline 
was 0.4030 (SD 0.1026) in the stepped care group and 0.3843 (SD 0.1164) in the minimal intervention 
group. The corresponding QALY gains for the 12 months from baseline were 0.8067 (SD 0.2012) and 
0.7717 (SD 0.2214), respectively.
TABLE 23 Mean health and social care and criminal justice service utilisations 
Resource item
Baseline 6 months 12 months
Control Intervention Control Intervention Control Intervention
A&E visit 0.15 (0.58) 0.13 (0.47) 0.17 (0.49) 0.17 (0.64) 0.14 (0.61) 0.09 (0.36)
Inpatient night 0.21 (1.24) 0.48 (3.59) 0.20 (1.02) 0.19 (1.00) 0.44 (2.74) 0.16 (0.98)
Outpatient 
attendance
1.01 (1.86) 1.00 (2.56) 1.03 (2.77) 0.97 (2.09) 1.10 (3.47) 0.91 (2.22)
Day case attendance 0.14 (0.68) 0.14 (0.53) 0.17 (0.70) 0.15 (0.58) 0.22 (2.29) 0.16 (0.54)
Use of emergency 
ambulance
0.05 (0.32) 0.06 (0.27) 0.10 (0.42) 0.04 (0.21) 0.10 (0.57) 0.02 (0.15)
Use of patient 
transport service
0.02 (0.28) 0.07 (0.38) 0.02 (0.17) 0.07 (0.59) 0.15 (1.75) 0.01 (0.14)
GP visit (surgery) 2.45 (2.68) 2.20 (2.19) 2.03 (2.20) 1.83 (1.90) 2.31 (2.90) 1.80 (1.98)
GP visit (home) 0.01 (0.10) 0.03 (0.26) 0.01 (0.10) 0.08 (0.63) 0.06 (0.44) 0.06 (0.45)
Practice nurse visit 
(surgery)
1.26 (1.88) 1.46 (2.50) 1.17 (1.93) 1.58 (5.35) 1.26 (2.05) 1.01 (1.42)
Practice nurse visit 
(home)
0.01 (0.21) 0.57 (8.24) 0.07 (0.54) 0.02 (0.17) 0.10 (1.14) 0.01 (0.15)
Prescriptions 4.12 (5.75) 3.58 (2.86) 3.87 (4.04) 4.09 (4.12) 3.83 (3.25) 3.60 (3.39)
Day centre visit 0.52 (5.77) 0.23 (3.30) 0.02 (0.23) 0.23 (3.30) 0.20 (1.74) 0.24 (3.30)
Meals on wheels 0.03 (0.41) 0.03 (0.41) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00)
Social services home 
care services
0.00 (0.00) 0.08 (0.71) 0.00 (0.00) 0.00 (0.07) 0.03 (0.41) 0.01 (0.15)
Social worker (office) 
(30 minutes)
0.06 (0.83) 0.00 (0.07) 0.03 (0.41) 0.01 (0.15) 0.02 (0.17) 0.03 (0.30)
Social worker (home) 
(60 minutes)
0.02 (0.28) 0.00 (0.00) 0.03 (0.41) 0.01 (0.15) 0.06 (0.83) 0.00 (0.00)
Care worker (office) 
(30 minutes)
0.01 (0.21) 0.00 (0.00) 0.02 (0.21) 0.20 (1.83) 0.20 (1.86) 0.04 (0.44)
Care worker (home) 
(60 minutes)
0.07 (0.59) 0.01 (0.10) 0.01 (0.14) 0.00 (0.07) 0.06 (0.46) 0.06 (0.46)
Police and criminal 
justice system 
contacts
0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00)
A&E, accident and emergency.
Note: Units correspond to units of resources consumed.
© Queen’s Printer and Controller of HMSO 2013. This work was produced by Watson et al. under the terms of a commissioning contract issued by the Secretary of State for 
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
DOI: 10.3310/hta17250 HealtH tecHnOlOgy assessment 2013 VOl. 17 nO. 25
37
Similar to the cost calculation, there is imbalance occurring at the baseline in the mean EQ-5D scores 
in the two trial groups (Table 26). After adjusting QALYs for baseline EQ-5D, the results demonstrate 
that participants in the stepped care group had, on average, a slightly better quality of life than those 
in the minimal intervention group [difference in QALYs was 0.0058 (95% CI –0.0018 to 0.0133) at 
6 months and 0.0117 (95% CI –0.0084 to 0.0318) at 12 months]. However, this difference was not 
statistically significant.
TABLE 24 Costs of health-care and social services resources used for each group at baseline, 6-month and 12-month 
follow-up (n = 422)
Costs
Stepped care, £ (SD) 
(n = 212)
Minimal intervention, 
£ (SD) (n = 210) Difference (£)a (95% CI)
Six-month resource use at 
baseline
522.53 (1233.05) 468.25 (727.41) 54.28 (–139.67 to 248.23)
Six-month resource use at 
6-month follow-up 
443.78 (832.70) 467.52 (903.42) –23.74 (–189.96 to 142.49)
Six-month resource use at 
12-month follow-up
410.65 (729.81) 602.38 (2263.20) –191.74 (–512.90 to 129.43)
Opportunistic screening cost 5.52 (0.00) 5.52 (0.00) 0
Intervention cost 46.63 (145.88) 2.34 (0.00) 44.29 (24.50 to 64.08)
Costs at 6 monthsb 495.53 (843.78) 474.98 (903.42) 20.56 (–146.75 to 187.87)
Costs at 6 monthsc 488.48 (826.32) 482.10 (826.32) 6.38 (–164.09 to 151.33)
Costs at 12 monthsb 906.18 (1369.31) 1077.36 (2635.77) –171.18 (–574.06 to 231.70)
Costs at 12 monthsc 895.04 (2049.45) 1088.61 (2049.47) –193.57 (–585.06 to 197.93)
a Difference =costs for intervention group – costs for control group.
b No adjustment.
c Adjusted for baseline resource use.
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FIGURE 3 Mean EQ-5D scores at baseline, 6 months and 12 months.
NIHR Journals Library www.journalslibrary.nihr.ac.uk
ecOnOmIc analysIs
38
Results of the cost-effectiveness analysis
Table 26 presents ICERs that combined the costs of interventions with health outcomes.
At the 6-month follow-up, both mean QALY gains and mean cost were greater in the stepped care group 
than in the minimal intervention group, generating an ICER of £1100 per QALY gained, while at the 
12-month follow-up, minimal intervention is dominated by stepped care using the calculated average 
results. Stepped care participants receive more benefits (greater QALY gains) for less cost; however, 
none of the differences in costs and benefits between the two interventions was statistically significant. 
The bootstrap method was therefore employed to evaluate uncertainty surrounding cost-effectiveness 
estimates. Bootstrapping results were also used to generate incremental CEPs and CEACs to show 
uncertainty surrounding adoption decisions, shown in Figures 4 and 5.
For the 6-month follow-up period, the incremental cost-effectiveness plane (Figure 4) showed over half 
of the plots falling into the south-east quadrant, indicating that stepped care interventions were less 
costly and more effective. Given WTP thresholds of £20,000–30,000 per additional QALY gained, which 
is the decision-making threshold used by NICE, the probability that stepped care was more cost-effective 
is 81.3–86.4%.
Similarly, at the 12-month follow-up (Figure 5), the majority of plots in the cost-effectiveness scatter 
lay in the south-east quadrant and indicated that minimal intervention was dominated by stepped care 
interventions. The probability of stepped care being cost-effective was between 93.5–93.84% using NICE’s 
threshold range of £20,000–30,000 per QALY gained.
The effects of the GP practice were analysed using a multilevel model programmed in MLwiN. Net 
monetary benefit was calculated using a WTP threshold of £30,000 per QALY. The analysis indicated that 
the net monetary benefit did not significantly differ by GP practice.
TABLE 25 Utility scores (EQ-5D index scores) and QALYs (n = 422) 
Outcome
Intervention group 
(SD) (n = 212)
Control group (SD) 
(n = 210) Difference,a £ (95% CI)
Baseline EQ-5D scores 0.8066 (0.2204) 0.7767 (0.2507) 0.0299 (–0.0152 to 0.0751)
Six-month follow-up EQ-5D 
scores
0.8052 (0.2238) 0.7606 (0.2451) 0.0446 (–0.0003 to 0.0895)
Twelve-month follow-up EQ-5D 
scores
0.8098 (0.2304) 0.7891 (0.2257) 0.0207 (–0.0229 to 0.0644)
QALY (6 months)b 0.4030 (0.1026) 0.3843 (0.1164) 0.0186 (–0.0024 to 0.0396)
QALY (6 months)c 0.3966 (0.0394) 0.3908 (0.0394) 0.0058 (–0.0018 to 0.0133)
QALY (12 months)b 0.8067 (0.2012) 0.7717 (0.2214) 0.0350 (–0.0055 to 0.0755)
QALY (12 months)c 0.7951 (0.1054) 0.7834 (0.1054) 0.0117 (–0.0084 to 0.0318)
a Difference = utility for intervention group – utility for control group.
b No adjustment.
c Adjusted for baseline EQ-5D scores.
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Results of the sensitivity analysis
Sensitivity analysis was carried out to check on costing methods in the economic evaluation. In total, 
13 participants with extreme costs were excluded in the sensitivity analysis. The changes in costs were 
noticeable (Figure 6). Taking the 12-month resource use as an example, the mean cost for the control 
group fell from £1162 to £850, and the standard deviation dropped from £2636 to £1125. With the 
409 cases left, the incremental cost-effectiveness analysis was repeated. The results are summarised 
in Table 27.
TABLE 26 Results of incremental cost-effectiveness analysis (completed cases) 
Outcome
6 months 12 months
Stepped care 
(n = 212)
Minimal intervention 
(n = 210)
Stepped care 
(n = 212)
Minimal intervention 
(n = 210)
Cost (SD) £488 (£826) £482 (£826) £895 (£2049) £1089 (£2049)
QALY (SD) 0.3966 (0.0394) 0.3908 (0.0394) 0.7951 (0.1054) 0.7834 (0.1054)
ICER (95% CI) –£1100 per QALY (–£85,991 to £95,546) –£7997 per QALY (–£238,341 to £172,319)
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FIGURE 4 Cost-effectiveness plane (a), adjusted for baseline utility and costs, and cost-effectiveness acceptability 
curve (b), adjusted for baseline utility and costs, at 6 months (completed cases). 
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Taking into account the sensitivity analysis, stepped care continues to demonstrate greater mean QALY 
gains; however, it is now more costly. The plots on the CEPs move upwards and to the left compared 
with base-case results. Now the adoption of the intervention relies only on the WTP threshold. Using the 
NICE threshold range of £20,000–30,000 per QALY, stepped care, with an incremental cost per QALY 
gained of £8496 at 6 months and £4224 at 12 months, is the more cost-effective option compared with 
minimal intervention.
Under the new set of ICERs, and using the £20,000–30,000 per QALY gained threshold, the probability 
that stepped care is more cost-effective ranges between 80% and 88% at 6 months and between 87% 
and 90% at 12 months (Figures 7 and 8).
Summary
The cost-effectiveness results indicated that the costs of delivering stepped care interventions were of the 
order of 20 times those of the minimal intervention [£46.63 (SD £146) vs £2.34 (SD £0)]. However, the 
overall cost per patient, taking into account health and social care resource use, was £488 (SD £826) in 
the stepped care group and £482 (SD £826) in the minimal intervention group at 6 months. The mean 
QALY gains were slightly greater in the stepped care group than in the minimal intervention group, with a 
mean difference of 0.0058 (95% CI –0.0018 to 0.0133), generating an ICER of £1100 per QALY gained. At 
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FIGURE 5 Cost-effectiveness plane (a) and cost-effectiveness acceptability curve (b) at 12 months (completed cases).
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month 12, participants in the stepped care group incurred fewer costs, with a mean difference of –£194 
(95% CI –£585 to £198), and had gained 0.0117 more QALYs (95% CI –0.0084 to 0.0318) compared with 
the control group. From an economic perspective, therefore, the minimal intervention was dominated by 
stepped care.
The results, based on the resampled cost-effectiveness data from the bootstrapping, showed that the 
probability of stepped care being cost-effective was between 81% and 86% at the 6-month follow-up, 
and 93.5% and 93.8% at 12 months’ follow-up given the NICE decision-making threshold range of 
£20,000–30,000 per QALY gained. This provides decision-makers with some useful evidence that stepped 
care interventions are more likely to achieve better value for money than minimal interventions. However, 
caution is required when interpreting the results given the uncertainty surrounding the estimates.
A sensitivity analysis that excluded extreme cases altered the average costs of interventions; the ICERs were 
£8496 per QALY at 6 months and £4224 per QALY at 12 months. The probability that stepped care is 
more cost-effective ranges between 80% and 88% at 6 months and between 87% and 90% at 12 months 
using the £20,000–30,000 per QALY gained WTP threshold.
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FIGURE 6 Twelve-month health and social care resource use before and after removing extreme cases.
TABLE 27 Results of incremental cost-effectiveness analysis (sensitivity analysis) 
Outcome
6 months 12 months
Stepped care 
(n = 206)
Minimal intervention 
(n = 203)
Stepped care 
(n = 206)
Minimal intervention 
(n = 203)
Cost (SD) £430 (£530) £368 (£530) £827 (£1029) £754 (£1029)
QALY (SD) 0.3999 (0.0386) 0.3926 (0.0387) 0.8030 (0.1027) 0.7857 (0.1027)
ICER (95% CI) £8496 per QALY (–£30,395 to £73,223) £4224 per QALY (–£37,867 to £57,965)
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FIGURE 7 Cost-effectiveness plane and cost-effectiveness acceptability curve at 6 months (sensitivity analysis).
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FIGURE 8 Cost-effectiveness plane and cost-effectiveness acceptability curve at 12 months (sensitivity analysis).
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Chapter 6 Fidelity process rating
Treatment fidelity plays a crucial role in considering the inferences drawn from effectiveness studies.66 It provides a means of evaluating whether or not therapists delivered the interventions as described 
in the session protocols and demonstrates that interventions were distinguishable from one another.96 In 
other words, it reports on the internal validity of the study. It also assesses the quality of such delivery, i.e. 
it measures practitioner skill. This is particularly important as treatment adherence is not always related 
to therapist competence.97 A therapist can adhere to a session protocol but deliver the components in a 
poor or unacceptable manner, such as asking questions at inappropriate times and adopting a cold and 
judgemental demeanour. Fidelity checks can therefore identify differences in therapist competence and 
enable potential treatment effects to be accurately attributed.
Methods
Development of the rating scale
The AESOPS PRS (Appendix 10) was adapted from the validated UKATT PRS66 and was designed to rate 
the delivery of all three trial interventions, namely the minimal intervention, the 20 minutes of BCC (step 1) 
and MET (step 2). Content and style items from the validated UKATT PRS, including those that rated the 
delivery of MET, were used as the basis for adapting the scale. These items were examined to ensure that 
they covered all of the treatment components specified in the session protocols. At this point an item was 
added to rate the number of open questions asked by the practice/research nurse.
Items described behaviours that were referred to in each of the session protocols and were therefore 
relevant to each intervention. Style items were largely based on a motivational interviewing approach. 
In order to distinguish interventions delivered in this style, two items denoting behaviours that were 
inconsistent with a motivational interviewing approach were included in the pilot phase. These included 
item 15, the extent to which the practice/research nurse provided unsolicited advice to the patient, and 
item 17, the number of closed questions asked by the practice/research nurse within the intervention.
The rating scale
The PRS is an 18-item scale, divided into four sections. The first section contains four items relating to 
overall session management. The middle two sections include eight items measuring specific tasks and 
five items measuring therapist style. The last section, listed as a single item, contains a session content/
activity checklist.
All but three items were rated on two 5-point scales. The first scale provided a frequency rating that 
showed the extent to which an item was present. The second scale gave a quality rating and showed how 
well the practice/research nurse performed the behaviour; this scale was rated only if the item received 
a frequency rating. The frequency ratings ranged from 0 (‘not at all’), indicating that the item never 
explicitly occurred, to 4 (‘extensively’), signifying that the item was performed numerous times during the 
intervention. Intermittent points were labelled ‘a little’, ‘somewhat’ and ‘considerably’. On the quality 
scale, a rating of 0 (‘very poor’) showed that the item was performed in an unacceptable manner, and a 
rating of 4 (‘very well’) indicated that the therapist had demonstrated a high level of skill and expertise. 
Intermittent labels were ‘poor’, ‘good enough’ and ‘well’.
Global ratings were given for three of the items; two were associated with session management (‘session 
structure’ and ‘consistency of problem focus’) and one with therapist style (‘empathy’). The remaining 
items consisted of frequency counts of specific behaviours with corresponding quality ratings. Each 
point on the frequency scale related to a predefined number of behaviour counts. For example, a 
frequency rating of 2 (‘somewhat’) indicated that the item behaviour occurred either once and in some 
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detail or three or time times but briefly. Quality scores also had corresponding definitions; for instance, 
0 (‘very poor’) indicated that the practice/research nurse performed the behaviour within each item in 
an unacceptable manner. Where appropriate, an average quality score was given for each of the item 
behaviours. For example, if a practice/research nurse attempted to elicit optimism three times within the 
intervention and received quality scores of 2, 3 and 4, the overall quality rating given for that behaviour 
would be 3 (‘well’).
Two items carried a frequency rating only: item 15 (‘unsolicited advice’) and item 17 (‘closed questions’). 
Given that these behaviours were inconsistent with a motivational interviewing style, it followed that a 
rating of how well therapists performed these items was not needed. The final item, a session content/
activity checklist, asked for a yes/no answer to illustrate whether or not the following content had 
occurred within the intervention: review AUDIT score, obtain an account of drinking, give correct advice/
information, set a target, and make a drinking plan. The checklist also included a tick box question to 
indicate whether the recording was good or poor.
The rating manual
The rating manual was similarly adapted from that used in the UKATT study.66 General guidelines were 
issued for the process of rating, such as rating practice/research nurse behaviours, distinguishing between 
frequency and quality scores, and avoiding sources of rater bias. Item definitions with guidelines for 
making higher or lower ratings were provided. These were illustrated with examples of practice/research 
nurse dialogue and differentiated from closely related items. Explanatory notes were included regarding 
the rating of session content.
Rater training and supervision
An independent rater was trained to use the adapted scale and rating manual. Supervised practice ratings 
were held at weekly intervals reviewing a total of 17 recordings split evenly between the trial interventions. 
Recordings were simultaneously rated and the scores discussed with reference to the manual and rater 
notes. This ensured rater consistency and prevented rater drift. Familiarity with the manual and rating 
scale was essential. Independent practice was carried out whereby item definitions were read each time 
they were scored. Recordings used during rater training were not used in the study. Regular supervision 
continued after training to discuss independently rated recordings. Selected recordings were rated by the 
independent rater and the supervisor for the purposes of calibration.
The process of rating
Following guidelines outlined in the rating manual, raters listened to the interventions and scored item 
behaviours. Where appropriate, frequency counts were given a corresponding quality rating. Item 
definitions, as specified in the manual, were referred to throughout the process in order to prevent rater 
drift. Raters had the option to pause the recording or consult the manual without stopping. Brief notes 
were made during the session to help substantiate assigned scores. These were particularly useful for 
discussing ratings during supervision. At the end of the session, appropriate global ratings and overall 
frequency and quality ratings were given. Each session was timed to ascertain duration. All scores were 
entered into the Statistical Package for Social Sciences (SPSS) version 19 (SPSS Inc., Chicago, IL, USA) 
for analysis.
Sampling
One hundred and sixty sessions of brief advice (minimal) and BCC (step 1) were selected for independent 
process rating (Figure 9). Only these two treatments were rated, as there were not enough MET sessions 
(step 2) to enable meaningful results to be obtained. The sample was stratified by site, practice/research 
nurse and treatment. Replacement sampling was used for eight inaudible recordings. In total, 79 
sessions of brief advice and 81 sessions of BCC were rated. Nineteen per cent of these were double rated 
(i.e. scored by both the independent rater and supervisor): 11 sessions of brief advice and 20 of BCC.
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Analyses
The PRS consisted of four sections: session management, specific task, practice/research nurse style 
and session content. The summaries for the scores for each of the treatment sessions are displayed 
in Tables 28 to 32.
Four summary measures were calculated; these were used in the analyses in addition to the time taken to 
complete the sessions. The summary measures were analysed using mixed models, with practice/research 
nurse fitted as a random effect. There was a significant difference in time of session between the 5- and 
20-minute sessions. The average time for the 5-minute session was 422.57 seconds (7 minutes) and for 
the 20-minute session 1174.78 seconds (20 minutes).
The 20-minute sessions had significantly higher task frequency and task quality scores. The 20-minute 
sessions also had significantly higher style frequency and style quality scores. The results can be seen 
in Table 33.
When comparing the session content, there were significant differences between the two sessions on only 
two measures, ‘obtaining a drinking account’ and ‘setting a target’; both of these were more likely to be 
performed in the 20-minute sessions. The results of all of the analyses can be seen in Table 34.
The analysis of the summary measures was repeated but this time it included a variable to represent 
specialist practitioners. When comparing the session rating scores for specialist and non-specialist 
practitioners there were no significant differences found. The full results can be seen in Table 35.
Reliability of ratings
A sample of the recordings was rated by two raters. Inter-rater reliability of the individual frequency items 
of the summary scores was examined using the ICC two-way mixed-effects model (case 3).67 For the four 
Independent rater training
17 supervised practice ratings
3% of total sessions (n = 529)
Independent process rating
160 sessions rated
30% of total sessions (n = 529)
Double ratings for calibration
21 sessions double rated
19% of total sessions (n = 160)
Brief advice
11 sessions
37% of minimal sessions (n = 79)
BCC
20 sessions
25% of stepped care sessions (n = 81)
Brief advice
79 sessions
30% of minimal sessions (n = 263)
BCC
81 sessions
30% of stepped care sessions (n = 266)
FIGURE 9 Flow diagram of process rating procedure.
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TABLE 28 Session management 
Management
Intervention
Stepped care (n = 81) Minimal (n = 79) Total
Maintaining structure
Frequency, mean (SD) (min., max.) 1.9 (0.7) (0, 4) 1.8 (0.6) (1, 3) 1.8 (0.6) (0, 4)
Quality, mean (SD) (min., max.) 1.7 (0.8) (0, 4) 1.6 (0.6) (0, 3) 1.7 (0.7) (0, 4)
Agenda setting
Frequency, mean (SD) (min., max.) 0.9 (0.6) (0, 2) 0.8 (0.4) (0, 2) 0.9 (0.5) (0, 2)
Quality, mean (SD) (min., max.) 1.0 (1.0) (0, 4) 0.8 (0.8) (0, 3) 0.9 (0.9) (0, 4)
Consistency of problem focus
Frequency, mean (SD) (min., max.) 1.9 (1.1) (0, 4) 2.0 (1.1) (0, 4) 2.0 (1.1) (0, 4)
Quality, mean (SD) (min., max.) 1.9 (1.1) (0, 4) 2.0 (1.1) (0, 4) 2.0 (1.1) (0, 4)
End of session
Frequency, mean (SD) (min., max.) 0.2 (0.5) (0, 2) 0.1 (0.3) (0, 2) 0.2 (0.4) (0, 2)
Quality, mean (SD) (min., max.) 0.3 (0.8) (0, 3) 0.0 (0.2) (0, 2) 0.2 (0.6) (0, 3)
max., maximum; min., minimum.
TABLE 29 Specific tasks
Tasks
Intervention
Stepped care (n = 81) Minimal (n = 79) Total
Drinking: feedback/negative consequences
Frequency, mean (SD) (min., max.) 0.9 (0.6) (0, 3) 0.9 (0.4) (0, 2) 0.9 (0.5) (0, 3)
Quality, mean (SD) (min., max.) 0.2 (0.5) (0, 2) 0.2 (0.4) (0, 2) 0.2 (0.5) (0, 2)
Eliciting client concerns about drinking
Frequency, mean (SD) (min., max.) 1.6 (1.1) (0, 4) 0.6 (0.7) (0, 3) 1.1 (1.0) (0, 4)
Quality, mean (SD) (min., max.) 0.7 (0.8) (0, 2) 0.3 (0.6) (0, 2) 0.5 (0.7) (0, 2)
Eliciting self-efficacy for change
Frequency, mean (SD) (min., max.) 0.7 (0.8) (0, 3) 0.1 (0.3) (0, 1) 0.4 (0.7) (0, 3)
Quality, mean (SD) (min., max.) 0.7 (0.9) (0, 3) 0.1 (0.3) (0, 2) 0.4 (0.8) (0, 3)
Commitment to drinking goal
Frequency, mean (SD) (min., max.) 1.3 (0.9) (0, 3) 0.7 (0.6) (0, 2) 1.0 (0.8) (0, 3)
Quality, mean (SD) (min., max.) 1.1 (0.8) (0, 3) 0.6 (0.6) (0, 2) 0.9 (0.8) (0, 3)
Ambivalence
Frequency, mean (SD) (min., max.) 0.3 (0.5) (0, 3) 0.0 (0.0) (0, 0) 0.1 (0.4) (0, 3)
Quality, mean (SD) (min., max.) 0.3 (0.7) (0, 3) 0.0 (0.0) (0, 0) 0.2 (0.5) (0, 3)
Creating conflict
Frequency, mean (SD) (min., max.) 0.1 (0.4) (0, 2) 0.0 (0.0) (0, 0) 0.1 (0.3) (0, 2)
Quality, mean (SD) (min., max.) 0.1 (0.4) (0, 2) 0.0 (0.0) (0, 0) 0.1 (0.3) (0, 2)
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Tasks
Intervention
Stepped care (n = 81) Minimal (n = 79) Total
Eliciting commitment to change drinking
Frequency, mean (SD) (min., max.) 1.0 (0.7) (0, 3) 0.2 (0.4) (0, 1) 0.6 (0.7) (0, 3)
Quality, mean (SD) (min., max.) 0.8 (0.8) (0, 3) 0.2 (0.5) (0, 3) 0.5 (0.7) (0, 3)
Eliciting optimism for change
Frequency, mean (SD) (min., max.) 1.1 (0.8) (0, 3) 0.4 (0.7) (0, 3) 0.7 (0.8) (0, 3)
Quality, mean (SD) (min., max.) 0.8 (0.8) (0, 3) 0.3 (0.6) (0, 2) 0.5 (0.8) (0, 3)
max., maximum; min., minimum.
TABLE 30 Practice/research nurse style
Styles
Intervention
Stepped care 
(n = 81) Minimal (n = 79) Overall
Frequency reflective listening, mean (SD) (min., max.) 2.6 (0.9) (0, 4) 1.1 (0.9) (0, 3) 1.9 (1.2) (0, 4)
Quality reflective listening, mean (SD) (min., max.) 1.7 (0.6) (0, 3) 1.1 (0.8) (0, 3) 1.4 (0.8) (0, 3)
Frequency empathy, mean (SD) (min., max.) 1.9 (0.9) (0, 4) 1.3 (0.9) (0, 4) 1.6 (1.0) (0, 4)
Quality empathy, mean (SD) (min., max.) 1.9 (0.9) (0, 4) 1.4 (1.0) (0, 4) 1.7 (1.0) (0, 4)
Frequency unsolicited advice, mean (SD) (min., max.) 2.9 (1.2) (0, 5) 3.4 (1.0) (0, 4) 3.2 (1.1) (0, 5)
Frequency open questions, mean (SD) (min., max.) 2.7 (0.8) (0, 4) 1.0 (0.9) (0, 3) 1.9 (1.2) (0, 4)
Quality open questions, mean (SD) (min., max.) 1.9 (0.5) (0, 3) 1.4 (0.9) (0, 3) 1.7 (0.8) (0, 3)
Frequency closed questions, mean (SD) (min., max.) 3.1 (1.0) (1, 4) 2.1 (1.1) (1, 4) 2.6 (1.2) (1, 4)
max., maximum; min., minimum.
TABLE 31 Session content
Activity
Intervention
Stepped care (N = 81) Minimal (N = 79) Total (N = 160)
Review AUDIT score, n (%) 63 (79.7) 74 (91.4) 137 (85.6)
Obtain drinking account, n (%) 78 (98.7) 40 (49.4) 118 (73.8)
Give correct advice/information, n (%) 76 (96.2) 81 (100.0) 157 (98.1)
Set a target, n (%) 28 (35.4) 11 (13.6) 39 (24.4)
Make a drinking plan, n (%) 11 (13.9) 6 (7.4) 17 (10.6)
TABLE 29 Specific tasks (continued)
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TABLE 32 Summary measures
Measures
Intervention
Stepped care (20 minutes) Minimal (5 minutes) Total
Length of session (minutes and seconds)
Mean (SD) 19:41 (05:42) 07:10 (01:59) 13:21 (07:34)
Median (min., max.) 19:38 (03:17, 34:30) 06:57 (03:17, 12:57) 11:06 (03:17, 34:30)
Task frequency
Mean (SD) 0.88 (0.35) 0.36 (0.20) 0.62 (0.39)
Median (min., max.) 0.88 (0.00, 1.88) 0.38 (0.00, 0.88) 0.50 (0.00, 1.88)
Task quality
Mean (SD) 0.59 (0.41) 0.21 (0.22) 0.40 (0.38)
Median (min., max.) 0.50 (0.00, 1.75) 0.13 (0.00, 1.25) 0.25 (0.00, 1.75)
Style frequency
Mean (SD) 2.64 (0.47) 1.78 (0.53) 2.20 (0.66)
Median (min., max.) 2.80 (1.20, 3.60) 1.80 (0.40, 3.00) 2.20 (0.40, 3.60)
Style quality
Mean (SD) 1.87 (0.55) 1.27 (0.66) 1.56 (0.68)
Median (min., max.) 2.00 (0.33, 3.00) 1.33 (0.00, 2.67) 1.67 (0.00, 3.00)
max., maximum; min., minimum.
TABLE 33 Summary measures analyses
Measures
Stepped care intervention 
(20 minutes), mean (SD)
Minimal intervention 
(5 minutes), mean (SD)
Difference  
(95% CI) p-value
Length of session 
(seconds)
1174.78 (36.53) 422.57 (35.68) 752.22 (674.00 to 
830.44) 
p < 0.001
Task frequency 0.92 (0.04) 0.40 (0.04) 0.52 (0.44 to 0.61) p < 0.001
Task qualitya 0.59 (0.04) 0.21 (0.04) 0.38 (0.27 to 0.48) p < 0.001
Style frequencya 2.64 (0.06) 1.78 (0.06) 0.87 (0.71 to 1.02) p < 0.001
Style quality 1.82 (0.10) 1.22 (0.10) 0.60 (0.43 to 0.77) p < 0.001
a Mixed model failed to converge so results are from a linear regression model.
TABLE 34 Session content analyses
Activity
Stepped care 
(N = 81)
Minimal 
(N = 79) Odds ratio (95% CI) p-value
Review AUDIT score, n (%) 63 (79.7%) 74 (91.4%) 0.27 (0.05 to 1.42) 0.123
Obtain drinking account, n (%) 78 (98.7%) 40 (49.4%) 71.7 (4.00 to 1283.6) 0.004
Give correct advice/information, n (%)a 76 (96.2%) 79 (100.0%) 0.118
Set a target, n (%) 28 (35.4%) 11 (13.6%) 3.41 (1.49 to 7.80) 0.004
Make a drinking plan, n (%) 11 (13.9%) 6 (7.4%) 1.88 (0.81 to 4.35) 0.140
a Results from Fisher’s exact test.
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summary scores, the average of the two raters’ summary scores was plotted against the difference in their 
summary scores69 to make pairwise comparisons between raters (Figure 10).
The ICCs for the summary measures ranged from 0.64 to 0.81 (Table 36), which indicates acceptable levels 
of agreement.67
The Bland–Altman plots for each of the summary measures compare the two raters (Figure 10). A positive 
difference indicates that the second rater scores higher than the first rater. A negative difference indicates 
than the second rater scores lower than the first.
Summary
The scale identified significant differences between the 5- and 20-minute interventions, indicating that 
the two types of session were distinct. Validation of the rating showed an acceptable level of agreement 
between the raters. There were no significant differences in the rating scores between practice/research 
nurses with different levels of experience (specialist vs non-specialist practitioners).
TABLE 35 Comparison of specialist and non-specialist practitioners’ rating scores
Rating
Non-specialist, 
mean (SD) Specialist, mean (SD) Difference (95% CI) p-value
Task frequency 0.69 (0.04) 0.61 (0.05) 0.08 (–0.07 to 0.22) 0.260
Task qualitya 0.42 (0.04) 0.39 (0.04) 0.03 (–0.07 to 0.14) 0.135
Style frequency 2.29 (0.08) 2.18 (0.12) 0.11 (–0.21 to 0.43) 0.459
Style quality 1.46 (0.11) 1.65 (0.17) –0.18 (–0.62 to 0.26) 0.384
a Mixed model failed to converge so results are from a linear regression model.
TABLE 36 Intraclass correlation coefficient analyses of the individual frequency items of the summary scores
Rating and raters n Mean rating (SD) ICC (95% CI)
Task frequency
Rater 1 33 0.76 (0.45) 0.815 (0.624 to 0.908)
Rater 2 33 0.93 (0.50)
Task quality
Rater 1 33 0.51 (0.44) 0.670 (0.332 to 0.837)
Rater 2 33 0.82 (0.64)
Style frequency
Rater 1 33 2.30 (0.54) 0.736 (0.465 to 0.869)
Rater 2 33 2.41 (0.81)
Style quality
Rater 1 33 1.67 (0.60) 0.640 (0.271 to 0.822)
Rater 2 33 1.95 (0.85)
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FIGURE 10 Bland–Altman plots.
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FIGURE 10 Bland–Altman plots. (continued)
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Chapter 7 Discussion
Here we report the results of a large trial of a stepped care intervention versus a minimal intervention in the management of older hazardous alcohol users in primary care.
Six published systematic reviews focus specifically upon the effectiveness of brief interventions in primary 
care populations28–33 although many of the studies excluded older patients. There are no systematic reviews 
or subgroup analyses specifically focusing on older patient groups. This trial aimed to fill that gap and was 
conducted and reported in accordance with international guidelines for research excellence.98–101
One prompt to conduct this trial was research indicating the underdetection and misdiagnosis of 
hazardous alcohol use in older populations.16,17 It is generally considered that the prevalence of hazardous 
or harmful alcohol consumption in those aged ≥ 55 years is lower than the general population. Indications 
are that prevalence is between 15% and 25% of the general population.11 However, the findings of this 
study found the prevalence of hazardous drinking in the older population to be less than suggested by 
previous research. Only 7.5% of those screened were positive on the AUDIT screening questionnaire and 
the mean AUDIT score of those positive was 12.10 (SD 5.65).
The issues encountered in this trial highlight the fact that research can be difficult to conduct in primary 
care owing to a number of issues including staff time and workloads. However, the eventual successful 
recruitment appears to suggest that older populations are as willing and able to engage in research 
evaluations as the general population and, as demonstrated by the impressive questionnaire return rates, 
display a greater willingness to be followed up. This concurs with previous research that suggested that 
older populations are more compliant with follow-up protocols than younger populations.38,56
Key findings
This study aimed to compare the effects of a minimal intervention (a 5-minute, brief advice with the 
practice/research nurse involving feedback of the results of the screening and discussion regarding the 
health consequences of continued hazardous alcohol consumption) with a stepped care intervention 
(progression to next step determined by reassessment of alcohol consumption after each previous step). 
The primary hypothesis was that a stepped care intervention reduced alcohol consumption in older 
hazardous alcohol users compared with a minimal intervention post randomisation. We found no evidence 
of a difference in the ADD after 12 months of older hazardous alcohol users when comparing the stepped 
care group with the minimal intervention group at month 12 [stepped care 1.129 (SD 0.037) vs minimal 
intervention 1.104 (SD 0.037)]. At month 6, the stepped care group had a lower ADD than the minimal 
interventions group, but not significantly so.
When adjusting for baseline scores and including GP as a random effect, there was no evidence of any 
differences in ADD at month 6, or AUDIT-C score or the DPI score at month 6 or month 12.
We investigated changes in HRQoL from baseline using the SF-12.59 Our results showed that the stepped 
care group had both lower MCS and lower PCS than the minimal intervention group at months 6 and 12, 
although the differences were not significant at the 5% level. We cannot conclude that stepped care has 
any impact on HRQoL.
We evaluated whether or not stepped care was a more cost-effective treatment for the management of 
older alcohol users in primary care and the results revealed that, with longer follow-ups, stepped care 
generated greater cost savings (£194 at month 12 vs £6.38 at month 6) and greater QALY gains (0.0117 
at month 12 vs 0.0058 at month 6).
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The probability that stepped care was cost-effective was higher for the month 12 follow-up period 
(93.5–93.8%) than the month 6 follow-up (81–86%) under a conventional WTP threshold of £20,000–
30,000 per QALY. This indicated that participants may benefit more from stepped care in the longer 
term with the reduction of alcohol-related health problems in the future. The analysis indicated that 
the net monetary benefit did not significantly differ by GP practice. A few ‘extreme values’ were present 
in the distribution (those deviating by five times the standard deviation) which were excluded, and the 
incremental cost effectiveness analysis was repeated in a sensitivity analysis. The sensitivity analysis altered 
the average costs of interventions; however, there was still over 80% certainty that stepped care is more 
cost-effective than minimal intervention months using the £20,000–30,000 per QALY gained threshold.
The health economic findings raise important issues when contrasted with the null clinical effectiveness 
findings and some further consideration of the reasons why this may occur is needed.
Firstly, in economic evaluation, an ICER combines the costs of the interventions with health outcomes. 
The statistic of interest is the ICER, which is estimated on the basis of four statistics from two samples: 
the costs of the control and intervention groups (CC and CI) and the effects of the control and intervention 
groups (EC and EI). This allows us to take advantage of the power to detect a difference in the joint cost-
effectiveness outcome. In some cases, the power to detect a difference in this joint outcome exceeds the 
power to detect differences in either cost or effect alone. It is possible for a study to show no difference in 
clinical outcomes between interventions, but also to conclude that one intervention is more cost-effective 
than another, because that intervention costs less when the intervention’s costs and subsequent service use 
are taken into account.
Secondly, the decision rule in an economic evaluation differs from traditional effect analysis. We make 
decisions to adopt a health technology by comparing the estimated cost-effectiveness ratio with a 
predefined standard or threshold value; for example, the decision-making threshold used by NICE is 
£20,000–30,000 per additional QALY gain. Whether or not an intervention is cost-effective varies when 
the decision threshold changes. Whereas in statistics an intervention is considered to be more effective if 
the p-value of the difference is lower than 0.05, this is not the case in an economic evaluation.
Thirdly, the traditional way of interpreting the CI may sometimes be interpreted in different ways in 
economic evaluation. For example, a negative ICER can arise as a result of two completely different 
situations. One scenario is that the intervention is more effective and less expensive. On the other side, 
the intervention may have a greater cost and a worse effect (cost-ineffective intervention). Therefore, we 
use CEACs to summarise the evidence in support of the intervention being cost-effective for all potential 
values of the decision rules. The CEAC presents much more information on uncertainty than it does on CIs 
in economic analysis, as it presents the probability that the intervention is more effective than the control 
at different values for a decision-maker’s threshold, for example if willing to pay different values to gain 
one QALY.
It may be the case that the economic analysis indicates that with a far greater sample size a difference in 
effect of the interventions may become apparent. The sample analysed at the final outcome stage was 
greater than that estimated in the original sample size calculation and any small effect difference derived 
from a far larger sample would be unlikely to be a clinically important difference.
Consideration of possible explanations
The importance of the actual screening process itself cannot be excluded as having a possible impact 
on the alcohol consumption of some trial participants. Previous studies and reviews have reported 
possible reactivity to such assessments,77,102–105 although the exact effect is difficult to separate from 
the study interventions. The fact that the study involved the proactive opportunistic identification of 
people consuming alcohol at levels that may be detrimental to their health precluded the inclusion of a 
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no-treatment control. Ethical considerations meant that the study compared two active interventions. 
The control was a minimally acceptable brief intervention and the provision of an information leaflet. The 
population identified using opportunistic screening exhibited lower levels of alcohol use and lower levels 
of alcohol-related problems than treatment-seeking populations and both groups reduced consumption 
over the 12 months. It may be the case that more intensive interventions in this population are no more 
effective than minimal interventions and similar results have been found in both systematic reviews and 
primary research.28,34,106
The majority of participants engaged with both the minimal intervention and step 1 of the stepped care 
intervention and written comments on questionnaires were overwhelmingly positive in describing these. 
Of note was the fact that two-thirds of those assessed as eligible for referral to step 2 either cancelled 
or failed to attend. These findings are similar to other studies of stepped care for alcohol use in primary 
care,13 extended alcohol interventions for alcohol use in primary care106 and referrals for interventions 
in emergency departments.107 It may be the case that extended multiple session interventions are not 
considered acceptable to a large proportion of the non-treatment-seeking population, many of whom are 
consuming alcohol at levels towards the lower end of the severity spectrum.
The use of the same practice/research nurse to deliver both the minimal intervention and step 1 of the 
stepped care intervention could have resulted in contamination due to the distinction between the 
interventions blurring and elements from each being found in the other. Verification of intervention fidelity 
not only ensures that internal validity of a study is maintained but also that external validity is enhanced.108 
This was achieved in AESOPS by each of the treatment sessions being recorded and also the fact that 
the PRS that was subsequently conducted did indeed identify significant differences between the 5- and 
20-minute interventions, indicating that the two types of session were distinct. Therefore, in this study, 
having the same practice/research nurse deliver the minimal intervention and step 1 of the stepped care 
intervention is not considered to have affected the outcome.
In the early stages of the study, some problems had been encountered with participating practice nurses 
finding little time available to see study participants. As the recruitment methods changed, and an increase 
in potential participants identified was likely, the use of research/specialist practitioners was required 
(although the task of preparing and sending out the mailings did not involve the practice nurses). The 
possibility that these two groups (non-specialist and specialist) would be delivering the interventions 
differently was not proven by the PRS, where no significant differences in the rating scores between 
practice/research nurses with different levels of experience were found. We therefore do not consider this 
to have influenced the result in any way.
In the original study design we envisaged opportunistically screening patients as they attended the primary 
care centre and this being conducted by practice staff. In reality, difficulties in recruiting practices willing 
to engage in this process meant that the methods of recruitment had to be amended to include mail-out 
screening and the use of specialist study staff to intervene with the eligible population. This is an indication 
that opportunistic screening and the delivery of brief interventions embedded within primary care are not 
currently acceptable to primary care staff.
Comparison with previous research
Previous screening and intervention studies looking at alcohol use conducted in UK health-care settings52,57 
suggested that 80% of those screened positive tend to be eligible and 75% of those eligible tend 
to consent to randomisation. In this study we found that only 57% of eligible patients consented to 
randomisation. Although still to be explored, it did not go unnoticed that a number of patients, either 
by written comment or by telephone, expressed the feeling that the time of the researchers would be 
better spent tackling binge-drinking and the perceived alcohol problems in the younger ages groups often 
highlighted in the media.
NIHR Journals Library www.journalslibrary.nihr.ac.uk
DIscussIOn
58
In addition, the prevalence of hazardous alcohol consumption, inclusive of harmful consumption and 
possible dependence, in those aged ≥ 55 years was estimated at 15% in the general population11 and 
greater, at 25%, in those attending primary care.13 Screening results from this study found this to be 
only 7.5%.
The results of the clinical effectiveness aspects of the study appear to concur with recent research in the 
area. The population in question was an opportunistically identified population at the lower end of the 
alcohol use disorder spectrum. A recent systematic review of brief interventions in primary care28 found 
no additional benefit of more intensive versus briefer interventions. Primary research in the UK found no 
additional benefit of extensive brief lifestyle counselling over and above brief advice and the provision of 
an information leaflet for a general population identified opportunistically using AUDIT in primary care;106 
in addition, a recent US study comparing minimal intervention with more intensive intervention for older 
alcohol users found that although alcohol use reduced in both groups there were no significant differences 
between the groups.34 General population studies in primary care have established the benefits of brief 
interventions over and above no treatment controls28 and similar results have been reported for older 
people in primary care.35,36
MEDLINE, EconLit, and NHS Economic Evaluation Database were searched for economic evaluations of 
alcohol treatments. Fewer than 30 full economic evaluations that compare both the costs and health 
consequences were found in literature. Only one trial (STEPWICE) was available that compared cost-
effectiveness between stepped care and a 5-minute advice session.51 The result of the cost-effectiveness 
analysis of the STEPWICE trial was very similar to AESOPS, but with a much smaller sample size (n = 112). 
Both studies found that stepped care was more likely to be cost-effective compared with minimal 
intervention using the NICE threshold range of £20,000–30,000 per QALY gained.
There are several difficulties when making direct comparisons between existing economic evaluations of 
alcohol treatments. Firstly, the definition of the interventions varies between studies. For example, ‘brief 
intervention’ was used as a common comparator in clinical trials109–112 but studies define brief intervention 
differently in terms of contact length, content and style.113 Secondly, the evaluation of health consequences 
differs among studies. For instance, the most widely used outcome measurements were drinks per 
drinking day, binge-drinking episodes or heavy drinking, and percentage of days abstinent. Although 
some economic evaluations used QALYs as a health outcome measure following NICE’s guidance71,114 none 
focuses on a similar population or interventions to the AESOPS study.
Strength and limitations of the study
Although we had originally estimated that we would recruit 500 participants from 15 GP practices in three 
sites over an 18-month period, it took twice this time and many more GP practices: 53 across eight sites. 
However, we did successfully recruit our target number of older hazardous alcohol users. Our finding of no 
evidence of a difference is not likely to be due to a lack of power.
As a result of the initial slow recruitment rate, a change in recruitment method was required, moving 
away from the original design of opportunistic screening in GP practice waiting rooms to the adoption 
of the more extensive method of mailing out forms to all patients aged ≥ 55 years on a participating GP 
practice register. This change, however, not only provided evidence of the limitations of using opportunistic 
screening at practice attendance as a recruitment method, but also allowed us to estimate a much more 
robust prevalence rate of hazardous alcohol consumption in this patient group, while also resulting in our 
recruitment target being met.
The lower than expected prevalence rate may be due to response bias, whereby those who are consuming 
alcohol at higher levels are less likely to respond to the AUDIT questionnaire and participate in the study. 
Yet participants were given an option to respond anonymously and those who did so had lower mean 
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AUDIT scores than those who provided contact details, which may add further weight to the idea that the 
prevalence figure identified in the study is indicative of the true population prevalence rate. In addition, 
the study population was generalisable to the population of older alcohol users who were willing to be 
screened and to engage in an intervention to address their alcohol use.
In addition, there was a reluctance on the part of the primary care nurses to undertake these interventions, 
and reluctance on the part of the GPs to support their practice nurses in doing this. These issues 
individually, and together, made it difficult to pursue the protocol as designed without having to adapt 
in some way. This does, however, have important implications regarding the question of whether or not 
these sorts of interventions can be implemented in the primary care setting and it does not seem to be the 
case that practice nurses are enthusiastic about their delivery.
One limitation of this study was the low take-up by those referred to step 2 of the stepped care 
intervention. The precise reasons for this are unknown but a number of factors could be involved. These 
include possible unwillingness of participants to accept that their alcohol consumption was having a 
detrimental impact on their health, particularly if they consumed alcohol at lower levels of severity; 
unwillingness to reduce consumption any more than agreed in the initial session; or unwillingness or 
unavailability to attend more than one session. There may also be an issue with the time lag between 
identification of the problem and the intervention taking place, resulting in attendance being less likely.
Our previous experience in conducting RCTs in the fields of substance use (UKCBTMM), alcohol-using 
general adult populations (UKATT, STEPWICE) and elderly populations (RESPECT) indicate that, with 
rigorous follow-up regimes, loss to follow-up at 12 months would usually be in of the order of 20%. 
Taking these factors into account we had erred on the side of caution and allowed an attrition rate of 
30%. In fact, in AESOPS the overall follow-up rate at month 12 was 87.5%, with 86.8% followed up in the 
stepped care group and 88.2% in the minimal intervention group.
In the cost-effectiveness analysis we made very conservative assumptions to ensure that the costs of the 
stepped care intervention were not underestimated. We did not take into account the possibility that 
interventions may prevent and reduce alcohol-related disease and injury, which may result in considerable 
cost savings, especially if these costs and expected impacts on health status were modelled over a longer 
time period.115 The absence of any criminal justice events within this study does suggest that the economic 
consequences of hazardous and harmful alcohol consumption could be different for older people, but 
this would need further investigation. It should also be noted that the training costs for practice nurses to 
deliver minimal intervention were not included in the control group. We assumed that they had already 
received training to deliver brief advice during their student nurse or early career training. If this part of the 
training cost was added into the control group, the minimal intervention would turn out to be even more 
costly compared with stepped care.
Generalisability of the results
The AESOPS recruited from eight sites and 53 GP practices across England and Scotland, including both 
urban and rural locations, in GP practices of varying sizes. With the population group within AESOPS, 
we are confident that these results are broadly generalisable to the population who would engage in 
screening and intervention for alcohol use problems in general practice.
Implications for health care
The evidence from this trial shows that there is no clinical advantage of opportunistic screening in addition 
to stepped care over opportunistic screening and minimal intervention in terms of the reduction in alcohol 
NIHR Journals Library www.journalslibrary.nihr.ac.uk
DIscussIOn
60
consumption at 12 months post intervention in hazardous alcohol users aged ≥ 55 years who score ≥ 8 on 
the AUDIT, but there is some evidence that it may be cost-effective.
Implications for research
The experience of conducting this research in primary care settings, the implication that extended 
interventions are not acceptable to participants or practice staff in the management of hazardous alcohol 
use and have no additional benefit over screening and minimal interventions, the potential to target 
those with more entrenched harmful or possible dependent alcohol use who are not seeking treatment 
and the finding that stepped care interventions appear to produce economic benefits have the following 
implications for future research:
 z What factors facilitate or hinder the conduct of research in primary care settings?
 z What is the effectiveness and cost-effectiveness of community-based screening and self-directed ultra-
brief interventions for hazardous alcohol users compared with screening alone?
 z What is the effectiveness and cost-effectiveness of MET for non-treatment-seeking harmful and 
possibly dependent alcohol users delivered in primary care?
 z What are the longer-term clinical and economic impacts of stepped care interventions?
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Appendix 1 Study protocol
REC Ref: Short Title: HTAPRO5 
Document Name: Full protocol 
Version: 5.0 Date: 17/09/09
Project title
The effectiveness and cost-effectiveness of opportunistic screening and stepped care interventions for older 
hazardous alcohol users in primary care (06/304/142). 
Planned investigation 
Research objectives
 z To evaluate the effectiveness of stepped care interventions for older hazardous alcohol users in 
primary care.
 z To evaluate the cost-effectiveness of stepped care interventions for older hazardous alcohol users in 
primary care.
 z To screen 4170 primary care attendees aged 55 years or more for hazardous alcohol use using the 
AUDIT questionnaire.
 z To evaluate the acceptability and validity of opportunistically screening for hazardous alcohol use in 
older primary care attendees.
 z To estimate the prevalence of alcohol use disorders in an older primary care population.
 z To train 15 practice nurses in the delivery of behavioural change counselling.
 z To conduct a pragmatic randomised controlled trial comparing stepped care interventions with a 
minimal intervention for older hazardous alcohol users in primary care.
 z To randomise 500 hazardous alcohol users, with equal probability, to either a minimal intervention or 
stepped care.
 z To conduct 6 and 12 month follow ups on at least 70% of those randomised to assess alcohol 
consumption, alcohol related problems, quality of life and service utilisation.
 z To study the process of therapy as delivered by both practice nurses and trained therapists.
Existing research
There exists a wealth of evidence regarding the detrimental impact of hazardous alcohol consumption, 
consuming more than the weekly recommended number of standard alcohol units in any week (21 for 
males, 14 for females) or half of the recommended number of standard alcohol units in any one day 
(10 for males, 7 for females), on the physical and mental health of the population. It is estimated that 
hazardous alcohol consumption accounts for 150000 hospital admissions and between 15000 and 22000 
deaths per annum in the United Kingdom (Academy of Medical Sciences 2004). In the older population, 
those aged 55 years or more, hazardous alcohol consumption is associated with a wide range of physical, 
psychological and social problems. There is evidence of an association between increased alcohol 
consumption and increased risk of coronary heart disease, hypertension, haemorrhagic and ischaemic 
stroke (Department of Health 1995), increased rates of alcohol-related liver disease and increased risk 
of a range of cancers (Prime Ministers Strategy Unit 2004). Alcohol consumption is identified as one of 
the three main risk factors for falls (Wright & Whiley 1994), a major cause of morbidity and mortality in 
this population. The Royal College of Physicians estimates that 60% of older people admitted to hospital 
because of repeated falls, confusion, chest infections and heart failure have undiagnosed alcohol problems 
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(Royal College of Physicians 2002). Increased alcohol consumption in older age can also contribute to 
the onset of dementia and other age related cognitive deficits (Thomas & Rockwood 2001), Parkinson’s 
disease (Feuerlein et al 1986) and a range of psychological problems including depression and anxiety. 
Alcohol use is implicated in one third of all suicides in the older population (Crome et al 1991). It is 
estimated that 80% of those aged 65 and over regularly take prescribed medication and polypharmacy is 
common with a third taking at least four prescribed medications per day (Falaschetti et al 2002). Alcohol 
is a major contraindication for many of the drugs prescribed for older people and alcohol and medication 
interactions are a common phenomenon (Dunne 1994). Increased alcohol consumption in older age is 
also associated with a range of social problems including self-neglect, poor nutrition, social isolation and 
hypothermia (Woodhouse 1987).
The prevalence of hazardous alcohol consumption, this is inclusive of harmful consumption, in those aged 
55 years and over is generally lower than the general population. The most recent estimate derived from 
the Alcohol Needs Assessment research Project (Drummond et al 2005) indicates a prevalence of between 
15% and 25% and concurs with other estimates derived from the General Household Survey. There is also 
evidence that the prevalence rate in primary care attendees is higher than the general population (Coulton 
et al 2006). There is evidence that these prevalence rates are under-estimates of the true prevalence rate. 
Older people are less likely to seek treatment for alcohol use disorders (Callahan et al 1995) and alcohol 
related presentations are often atypical or masked by comorbid physical or psychiatric illness that makes 
alcohol related diagnosis more difficult (Reid et al 1997). In 2000 16% of the UK population was over 
the age of 65 and this is expected to increase to 21% by 2026 (Falaschetti 2000). As the average age of 
the population increases the absolute number of older people consuming alcohol at hazardous levels will 
increase even if the prevalence rate remains stable. Recent research using data derived from the General 
Practice Research Database indicates that only 5% of people aged 55 years or older with an alcohol use 
disorder are identified in primary care settings (Cheeta et al 2006). Opportunistic screening is a proactive 
screening technique that has been used with some success in a variety of health-care areas including type 
II diabetes (Johnson et al 2005) and Chlamydia (Tobin et al 2001) and is particularly useful in identifying 
conditions in populations who would not usually seek treatment.
A number of paper based screening methods have been developed to identify hazardous alcohol 
consumption, these include instruments such as the Michigan Alcohol Screening Test (Selzer 1971), 
Paddington Alcohol Test (Patton et al 2004), Fast Alcohol Screening Test (Hodgson et al 2002) and the 
Alcohol Use Disorders Identification Test (Saunders et al 1993). All have acceptable levels of sensitivity and 
specificity. The Alcohol Use Disorders Identification Test (AUDIT) was specifically developed for use in a 
primary care population and has 92% sensitivity and 92% specificity for identifying hazardous alcohol use 
in a UK primary care setting (Coulton et al 2006); more specifically in older populations AUDIT has been 
demonstrated to have higher sensitivity, 75%, and higher specificity, 97.2% than other screening tests 
when used in older populations (Philpot et al 2003). AUDIT is a short 10-item questionnaire that addresses 
frequency of alcohol consumption, alcohol related problems and alcohol dependence symptoms. Because 
of the evidence of under detection and misdiagnosis of hazardous alcohol use in older populations 
(Callahan 1995, Reid 1997) the proactive application of a short universal screening method is likely to be 
more appropriate. There is evidence that patients are more compliant with screening protocols for alcohol 
use in health-care settings and that the environment provides an opportunity for a ‘teachable moment’ 
increasing the patient’s likelihood to engage in an intervention (Crawford et al 2004).
There is a substantial evidence base for the efficacy of brief motivational interventions, aimed at reducing 
alcohol consumption in primary care. Studies have demonstrated the effectiveness of brief interventions 
in reducing alcohol consumption in primary care populations in the United Kingdom (Wallace et al 1998, 
Anderson et al 1992). Further, there are five systematic reviews focusing specifically upon the effectiveness 
of brief interventions in primary care populations (Bertholet et al 2005, Ballesteros et al 2004, Whitlock 
et al 2004, Poikolainen 1999, Kahan et al 1995) all conclude that brief interventions in primary care 
populations are effective in reducing alcohol consumption. But many of the studies included in these 
reviews exclude older patients. There are no systematic reviews or subgroup analyses specifically focussing 
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on older patient groups. There is some evidence from primary research of the efficacy of brief interventions 
specifically for older hazardous alcohol consumers. In a trial of brief interventions for older alcohol users in 
primary care in the United States, Fleming et al (1999) reported a 34% reduction in alcohol consumption 
and 64% reduction in those drinking at hazardous levels at 12 months, significantly better than those who 
received no intervention. Blow and Barry (2000) also report significantly greater reduction in alcohol use 
in older populations treated with brief interventions in primary care than controls. There is also evidence 
from subgroup analyses of existing studies that older patients are at least as likely to benefit from brief 
interventions than younger patients (Curtis 1989) and older adults are more likely to adhere and comply 
with brief intervention treatment regimes (Oslin et al 2002). While a number of brief intervention studies 
have addressed the issue of cost-effectiveness, few have addressed the issue from a pragmatic NHS 
perspective. The evidence of brief interventions has been criticised for failing to address a wider range of 
alcohol use disorders including harmful alcohol consumption (Rollnick 1999) and for failing to address 
more entrenched drinking behaviours.
Motivational enhancement therapy is a relatively short, usually three 40 min sessions delivered by a 
trained therapist, but more intensive intervention than a brief motivational intervention. Primary research 
has shown it to be as effective as other more intensive interventions such as cognitive behavioural 
therapy, twelve steps facilitation therapy and social behavioural network therapy (Project MATCH 1997; 
UKATT 2005).
Screening for alcohol use disorders identifies a range of needs that are likely to require a range of types 
and intensities of intervention. One of the primary reasons why many general practitioners are reluctant 
to implement screening into routine care is because they lack the skills of how to deal with the more 
severe cases identified (Deehan 1998). Older alcohol consumers are often typified as either ‘early-onset’ 
drinkers, whose consumption pattern is a continuation of lifetime hazardous consumption or ‘late-
onset’ drinkers whose alcohol consumption is a reaction to life events occurring in later life. ‘Late-onset’ 
drinkers’ are more likely to benefit from brief interventions than ‘early-onset’ drinkers who often require 
a more intensive intervention approach (Menninger 2002). Physiological changes that occur as part of 
the ageing process mean that older people are more vulnerable to alcohol and experience alcohol related 
problems at lower consumption levels than younger people. Stepped care interventions offer a potentially 
resource efficient means of meeting the needs of this population. Stepped care interventions provide 
a means of delivering more intensive interventions only to those who fail to respond to less intensive 
interventions and are more in keeping with rational clinical decision making than the blanket use of any 
one intervention strategy.
Hypotheses
Primary hypothesis
Stepped care interventions for older hazardous alcohol users reduce alcohol consumption compared with 
a minimal intervention.
Secondary hypotheses
1. Stepped care is more cost-effective than minimal intervention. 2. Stepped care will reduce alcohol 
related problems in comparison to minimal intervention. 3. Stepped care will increase health-related 
quality of life compared with minimal intervention. 4. Opportunistic screening will identify more hazardous 
alcohol users than usual practice.
Reference methods
The proposed study is a pragmatic randomised controlled trial evaluating the effectiveness and cost-
effectiveness of opportunistic screening and stepped care interventions for older hazardous alcohol users 
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in primary care. Primary care attendees aged 55 years or over who fulfil the eligibility criteria and provide 
informed consent will be individually randomised with equal probability to receive either stepped care 
or a minimal intervention. Baseline assessments will be conducted by the practice nurse and follow up 
assessments will be conducted by post, at 6 and 12 months after randomisation. Allocation to treatment 
group will be conducted by a remote randomisation service using random permuted blocks stratified by 
cluster. A full CONSORT statement indicating trial progress is attached in section 9 of this document.
Planned interventions
Screening
All primary care attendees, aged 55 years or older, will be provided with an information sheet, a copy of 
the AUDIT questionnaire and a return envelope addressed to the practice nurse on arrival at the practice 
by the practice receptionist. Returned questionnaires, enclosed in a sealed envelope, will be scored by the 
practice nurse by summing the responses to all 10 questions on the AUDIT questionnaire. Patients who 
score 8 or more on the AUDIT questionnaire will be invited to a research assessment with the practice 
nurse within 7 days. At the research assessment the research nurse will explain the study, provide an 
opportunity to ask any questions and ask the potential participant for informed consent. The research 
assessment will include a check on eligibility including an assessment of alcohol consumption using the 
extended AUDIT-C. If hazardous alcohol use is identified the patient will complete the rest of the baseline 
assessment and will be randomised using a remote randomisation service. Participants will be randomised 
with equal probability to either minimal intervention or stepped care.
Minimal Intervention
The minimal intervention consists of a short, 5 min, discussion with the practice nurse about the health 
consequences of continued hazardous alcohol consumption. The participant will also receive a brief 
self-help booklet ‘Safer drinking – a self help guide’ outlining the consequences of excessive alcohol 
consumption and providing information on sources of help for drinking problems locally and nationally.
Stepped Care Intervention
The stepped care intervention consists of three consecutive steps in which progression between steps are 
dependent upon the outcome of each previous step.
Step 1 will consist of a 20 min session of behavioural change counselling delivered by the practice nurse. 
This intervention, based upon an existing evidence base of brief interventions, utilises the technique of 
motivational interviewing (Rollnick et al 1999) and aims to address the individual’s motivation to change 
their drinking behaviour. The counselling is manual guided and practice nurses will be trained in the 
delivery. Four weeks after randomisation the participant will be contacted by the practice nurse and a short 
telephone assessment will be made about the participant’s alcohol consumption in the past 4 weeks using 
the extended AUDIT-C. If the participant is still consuming alcohol at hazardous levels a referral will be 
made to step 2 of the intervention.
Step 2 involves an intervention by a trained alcohol therapist in the primary care environment. The 
intervention, motivational enhancement therapy, is provided through 3, 40 min sessions on a weekly basis. 
The intervention is manual guided and addresses six basic principles of increasing motivation for change. 
Feedback about individual alcohol consumption, emphasis on the individual as being the agent responsible 
to change, advice on how to accomplish change, provision of alternative vehicles for change, maintenance 
of an empathetic therapeutic style and emphasis on enhancing the individuals self-efficacy. Four weeks 
after the last MET session the participant will be contacted by the practice nurse and a short telephone 
assessment will be made about the participant’s alcohol consumption in the past 4 weeks using the 
extended AUDIT-C. If the participant is still consuming alcohol at hazardous levels a referral will be made 
to step 3 of the intervention.
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Step 3 will consist of a referral to the local specialist alcohol services to receive specialist intervention, 
including as necessary detoxification, inpatient care, outpatient counselling, group therapy, relapse 
prevention treatment or medication. There is no limit on the intensity or duration of the step 
3 intervention.
Particular emphasis is being paid to ensure that the interventions are pragmatic in nature. The 
interventions will be delivered by staff routinely employed in primary care, in the case of practice nurses, 
and specialist alcohol services in the case of motivational enhancement therapists. All of the interventions 
will be manual guided to specify the purpose and principles of each intervention and the structure and 
content of each particular treatment session.
Training of practice nurses to deliver behavioural change intervention
It is proposed to train 15 practice nurses in the techniques and delivery of a brief motivational behavioural 
change intervention. Each practice nurse will spend 3 non-consecutive days at the training centre at Leeds 
Addiction Unit. Training will be provided by expert trainers in motivational interviewing. The training 
will take the form of simulated consultation/seminar/simulated consultation. Each nurse will have the 
opportunity to engage in a simulated consultation which is recorded. As a group the nurses will discuss 
the simulated consultations to examine and review application of motivational interviewing techniques. 
The process of simulation/seminar/simulation is repeated on a number occasions with actors who pose as 
a variety of potential patients. Prior to embarking on the study assessment of competency will be made 
using a recorded session rated by an independent expert. Practice nurses will be provided with ongoing 
supervision throughout the study provided by an expert trainer from Leeds Addiction Unit.
Training of therapists to deliver Motivational Enhancement therapy
It is proposed to train three alcohol therapists from local alcohol agencies. Therapists will have at least two 
years post-qualifying experience. Initial training will involve a three day intensive group training course 
provide by motivational enhancement trainers at Leeds Addiction Unit. Particular attention will be given 
to understanding the evidence base, understanding the theoretical basis of treatment, demonstration of 
practice and role-play opportunities. Therapists will be supervised in the delivery of a number of therapy 
sessions. Therapists will be expected to complete two taped sessions both reviewed in conjunction with 
a trained supervisor. Supervision will provide the main opportunity for practising skills and delivering the 
structure and content of treatment. Assessment of competence will depend upon the therapist’s ability 
to deliver motivational enhancement therapy according to the designation of treatment prescribed in the 
treatment manual.
Planned inclusion/exclusion criteria
Inclusion and exclusion criteria have been chosen to maintain a balance between ensuring the sample is 
representative of the primary care population whilst ensuring that the trial population are able to engage 
both with the interventions and follow up.
Inclusion criteria
1. Age 55 years or over at time of screening. 2. Diagnosis of an alcohol use disorder using AUDIT criteria. 
3. Residing in a stable place of residence. 4. Living within commutable distance of the primary care 
practice. 5. Providing informed consent for randomisation, treatment and follow up.
Exclusion criteria
1. Treatment for substance use in the past 90 days, excluding nicotine. 2. Already seeking help for an 
alcohol use disorder. 3. Received treatment for primary drug dependence, excluding nicotine in the past 
90 days. 4. Outstanding legal issues likely to lead to imprisonment. 5. Severe mental or physical illness 
likely to preclude active participation in treatment or follow up.
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Ethical arrangements
The study will only start once full MREC approval has been granted. There are no anticipated risks in 
relation to either treatment. There is no documented evidence of adverse events arising due to either the 
minimal intervention or the stepped care intervention.
Screening
In accordance with guidance on best practice, all attendees at primary care who are aged 55 years or 
older, will be informed by the practice receptionist that a study is taking place. They will be provided with 
an information sheet and a copy of the AUDIT questionnaire. The information sheet will provide details of 
the study taking place and make clear that completion of the screening questionnaire is not compulsory. 
Participants will have the option to not complete the questionnaire, to complete the questionnaire 
anonymously or complete the questionnaire with full contact details. Completed questionnaires will be 
returned to the receptionist in sealed envelopes.
Invitation to attend practice nurse assessment
All AUDIT positives who complete their contact details will be contacted by the practice nurse. Contained 
within the invitation will be a detailed information sheet providing information on the purpose of the 
study, the eligibility criteria, the proposed interventions and follow up assessments. Potential participants 
will be informed that participation is not compulsory.
Baseline assessments
At the baseline assessment the practice nurse will discuss the study and the process of assessment and 
provide the potential participant an opportunity to ask any questions about participation in the study. A 
standard baseline assessment will be conducted and all information recorded on forms that contain only 
an identification number. Eligible participants will be invited to provide written informed consent. For 
those who do consent, randomisation will be conducted using the secure remote randomisation service at 
York Trials Unit. At this point the patients contact details and identification number will be associated and 
held on a secure server located at the University of York. This master register will be held separate from 
the outcome data and accessible only to those who need to know for purposes of conducting the study. 
Randomisation will be conducted using block randomisation stratified by cluster with an equal probability 
of receiving stepped care or minimal intervention.
Follow up assessments
Follow up assessments will be conducted by post from the trials unit at the University of York.
Retention of trial data
All trial data will be identified using a unique trial identification number. No personally identifiable 
information will be held beyond the final 12 month follow up. Analytical datasets will not contain any 
patient identifiable information. Anonymised data will be retained for a period of 42 months.
Proposed sample size
There are no previous studies of stepped care interventions, a brief opportunistic intervention followed 
by successively more intensive interventions for those who fail to respond to treatment, for older 
alcohol using adults. The closest UK pragmatic randomised controlled trials include Wallace et al 1998 
and STEPWICE 2003, both of these reported effect size differences between stepped care and minimal 
intervention of 0.36 and 0.27 respectively. Similar effect size differences are reported in studies from 
the United States (Fleming 1999; Moyer et al 2003; Gordon et al 2003). There is evidence that older 
populations respond as well, or even better, to brief psychosocial interventions for alcohol use than general 
populations (Oslin et al 2002; Lemke et al 2003). Assuming a conservative effect size difference between 
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stepped care and minimal intervention of the order of 0.3 would require a sample size of 175 participants 
in each of the two randomised groups, using power at 80% and a 5% significance level.
Our previous experience in conducting randomised controlled trials in the fields of substance use 
(UKCBTMM), alcohol using populations (UKATT, STEPWICE) and elderly populations (RESPECT) indicate that 
with assiduous follow up regimes loss to follow up at 12 months is of the order of 20%. There also exists 
evidence that older populations are more compliant with treatment regimes and follow up protocols than 
younger populations (Atkinson 1995; Oslin et al 2002). Taking these factors into account we have erred on 
the side of caution and allowed a loss to follow up of 30%, requiring 500 participants to be randomised, 
250 in each group. Previous alcohol use screening and intervention studies conducted in UK health-care 
settings (Heather et al 1996; STEPWICE 2003) suggest that 80% of those screened positive tend to be 
eligible and 75% of those eligible tend to consent to randomisation. This means the study requires 834 
screen positives of whom we predict 500 will be eligible and consent to randomisation.
The prevalence of hazardous alcohol consumption, inclusive of harmful consumption, in those aged 
55 years or older is estimated at 15% in the general population (Drummond et al 2005) and greater, at 
25%, in those attending primary care (Coulton et al 2006). If we conservatively estimate the prevalence 
at 20% we would need to screen 4170 primary care attendees in an 18 month period. Assuming 15 
practices, in three geographic regions consent to take part in the study, each practice would be expected 
to screen 278 primary care attendees over 18 months, a total of 18 per practice per month.
Statistical analysis
Opportunistic screening
We will use a comprehensive cohort approach to the analysis of the acceptability and validity of 
opportunistic screening. Practice receptionists will keep records of the age and sex of all attendees 
offered an AUDIT questionnaire. Participants will have a choice of not completing the questionnaire, 
completing the questionnaire with basic age/sex demographics or completing the questionnaire with full 
contact details.
Effectiveness analysis
The primary analysis will be intention to treat comparing minimal intervention with stepped care on the 
primary outcome measure, average drinks per day, at 12 months post-randomisation. Participants will be 
analysed as part of the group allocated irrespective of treatment received. The primary outcome will be 
analysed using analysis of covariance controlling for baseline values. Multi-level modelling analysis will 
be undertaken to account for any variation due to centre, cluster and therapist. Primary analysis will be 
conducted after all 12 month follow ups have been completed. Analysis of secondary outcomes will be 
conducted using analysis of covariance and adjusted using multi-level modelling. Regression analysis will 
be undertaken to explore any baseline predictors of outcome, any baseline predictors of referral to step 2 
for the stepped care group and any potential baseline x treatment interaction effects.
Economic analysis
The incremental cost-effectiveness of stepped care compared to the minimal intervention will be assessed 
both from a health and personal social services perspective following NICE guidance (NICE, 2004) and 
a wider public sector resource perspective (NICE, 2006). While the opportunistic screening costs will be 
common to both intervention arms, its cost will be estimated from the trial data as this would form part 
of a wider implementation cost of the stepped care programme. The costs of the minimal intervention 
and the first two tiers of the stepped care programme will be based on information gathered on patient 
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contact with the primary care and specialist services during the trial. The units of service used will be 
based on the local costs of specialist services and include an allowance for the training and supervision 
costs, using methods developed for the UKATT trial (UKATT Research team, 2005b). Any use of more 
specialist services will be collected, including the type of intervention, and costs will be applied from 
previous research trials and a current Department of Health funded research project based on a range of 
specialist providers and intervention types (Raistrick et al, 2004). The use of alcohol services outside the 
trial protocol, along with all other public sector services, including health, social welfare and contact with 
criminal justice agencies will be assessed from questionnaires administered at baseline, 6 and 12 months. 
This service use questionnaire developed over a number of alcohol and illicit drug trials will be adapted 
for the specific needs of this project, for example, by additional questions on falls. Units recorded will be 
combined with national sources of unit costs (Netten et al, 2005; UKATT Research Team, 2005b). The 
EQ-5D will be used with population values and the QALY change calculated using the area under the curve 
method. Bootstrapping methods will be used to test to explore the sensitivity of the calculated incremental 
cost-effectiveness ratios and cost-acceptability curves presented.
Proposed outcome measures
Screening
Screening for alcohol use disorders will be conducted using the Alcohol Use Disorders Identification 
Test (AUDIT) (Saunders et al 1993). The instrument addresses alcohol consumption frequency and 
quantity, alcohol related problems and elements of alcohol dependence. The 10-item patient completed 
questionnaire takes approximately 3 min to complete and 2 min to score. A score of 8 or more indicates 
hazardous alcohol use. AUDIT exhibits high levels of sensitivity (92%) and specificity (92%) in UK primary 
care populations (Coulton et al 2006) and high levels of sensitivity (75%) and specificity (93%) in older 
populations (Philpot et al 2003).
Eligibility assessment
To establish eligibility a potential participant should score positive for the AUDIT questionnaire and be 
classified as a hazardous alcohol user using extended AUDIT-C criteria. Hazardous alcohol consumption is 
established if the participant has consumed more than 21 standard units for males, or 14 for females, in 
any one week or 10 standard units for males or 7 standard units for females in any 1 day in the previous 
90 days. The extended AUDIT-C is used to derive the primary outcome measure for the study.
Primary outcome measure
The primary outcome measure for the study is average drinks per day. This is ascertained using the time 
extended AUDIT-C. Three other variables can be derived from the data; percent days abstinent, drinks per 
drinking day and total alcohol consumed. The extended AUDIT-C is self-completed and takes approximately 
2 min to complete. The outcome is measured at baseline, 6 months post randomisation and 12 months 
post-randomisation.
Secondary outcome measures
1. Alcohol related problems measured at baseline, 6 months and 12 months post randomisation. Alcohol 
related problems are assessed using the 17-item participant completed Drinking Problems Index (DPI). The 
DPI has been specifically designed and validated for use in older populations (Finney et al 1991). 2. Quality 
of life is measured at baseline, 6 months and 12 months post randomisation. Quality of life is measured 
using the SF-12 (ware et al 1996). SF-12 is a 12-item self completed questionnaire that established validity 
and reliability for measuring physical health and mental health components of quality of life. 3. Health 
utility will be measured at baseline, 6 months and 12 months using the EQ-5D (Euroquol 1990). EQ-5D is 
a 5-item participant completed questionnaire with established reliability and validity in this population.
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Economic outcome measures
Opportunistic screening costs will be estimated from the actual costs of screening using the actual costs 
of screening associated with the study. Costs of delivering the minimal intervention and the first two tiers 
of stepped care will be based upon actual patient contact time from time sheets maintained by practice 
nurses and therapists. The units of services used will be based upon local costs of services and include 
allowances for managerial and premises overheads and the costs associated with training and supervision 
using methods utilised in similar intervention studies (UKATT 2005). The costs of any specialist referral will 
be costed using information on the actual costs associated with specialist service provision based upon 
Department of Health costs of specialist interventions (Raistrick et al 2004).
Participant use of health services, other alcohol services outside the study, public services and criminal 
justice services will be assessed using a service use questionnaire at baseline, 6 months and 12 months 
post randomisation. The service use questionnaire has been developed over a number of alcohol 
intervention studies (STEPWICE 2003; UKATT 2005) will be adapted to capture costs specifically associated 
with this population.
Quality assurance of treatment delivery
Participants will be asked to provide consent to have all treatment sessions recorded. A 20% sample of 
each type of treatment session, minimal intervention, behavioural change intervention, motivational 
enhancement therapy will be randomly selected stratified by treatment type. Tapes will be rated by an 
independent rater and assessed for quality of delivery and compliance with treatment protocols.
Research governance
The proposed study will be conducted in accordance with the MRC Guidelines on Good Clinical 
Practice in Clinical Trials. Prior to undertaking the study, full ethical approval will be sought from the 
Multicentre Research Ethics Committee. All data will be held in a secure environment identified by a 
unique participant identification number. Master registers containing patient identifiable information 
and participant identification numbers will be stored in a secure area separate from the majority of data. 
Data management will be conducted by York Trials Unit, a unit regularly inspected for the purpose of 
governance procedures.
The study organisation is presented in appendix 2. The study will be managed on a day to day basis by 
a trial manager in conjunction with the project manager. Regular meetings of the Trial Management 
Group will take place and twice yearly meetings of the Trial Steering Committee made up of independent 
members with clinical, methodological and statistical expertise. We will also invite a representative of a 
consumer group such as Age Concern.
Project timetable and milestones
Timetable
Months 1 – 6: Recruit participating practices, ethics application, develop clinical record forms, practice 
nurse training, therapist training, recruit research assessors.
Months 7 – 24: Screen 4170 participants in 15 primary care centres. Recruit 500 participants.
Months 12 – 30: Conduct 6 month follow ups
Months 18 – 36: Conduct 12 month follow ups
Months 36 – 42: Collate data, statistical and economic analysis and writing of report.
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Changes to protocol
In the North East region the project will be carried out in a different way. Changes to the protocol above 
refer to the sections looking at planned interventions (pages 4 and 5), training of practice nurses to 
deliver behavioural change intervention (page five), Screening (page 6), invitation to attend practice nurse 
assessment (page 7) and baseline assessments (page 7). These sections are shown below with changes 
made. Any practices in currently participating (as of 17/09/09) centres which have only recently come 
on board will be offered the opportunity to convert to this method or to remain using the opportunistic 
screening. New practices brought on board in future will screen using the mail out system.
Planned interventions
Screening
All primary care attendees, aged 55 years or older, will be posted a letter signed by the trial manager and 
the lead GP of the relevant practice as well as an information leaflet, a copy of the AUDIT questionnaire 
and a return envelope addressed to the trial manager. Returned questionnaires, enclosed in a sealed 
envelope, will be scored by staff in York by summing the responses to all 10 questions on the AUDIT 
questionnaire. Patients who score 8 or more on the AUDIT questionnaire will be invited to a research 
assessment with the Alcohol Health Worker within 7 days. At the research assessment the Alcohol 
Health Worker will explain the study, provide an opportunity to ask any questions and ask the potential 
participant for informed consent. The research assessment will include a check on eligibility including an 
assessment of alcohol consumption using the extended AUDIT-C. If hazardous alcohol use is identified 
the patient will complete the rest of the baseline assessment and will be randomised using a remote 
randomisation service. Participants will be randomised with equal probability to either minimal intervention 
or stepped care.
Minimal Intervention
The minimal intervention consists of a short, 5 min, discussion with the Alcohol Health Worker about the 
health consequences of continued hazardous alcohol consumption. The participant will also receive a 
brief self-help booklet ‘Safer drinking – a self help guide’ outlining the consequences of excessive alcohol 
consumption and providing information on sources of help for drinking problems locally and nationally.
Stepped Care Intervention
The stepped care intervention consists of three consecutive steps in which progression between steps are 
dependent upon the outcome of each previous step.
Step 1 will consist of a 20 min session of behavioural change counselling delivered by the Alcohol 
Health Worker. This intervention, based upon an existing evidence base of brief interventions, utilises the 
technique of motivational interviewing (Rollnick et al 1999) and aims to address the individual’s motivation 
to change their drinking behaviour. The counselling is manual guided and practice nurses will be trained 
in the delivery. Four weeks after randomisation the participant will be contacted by the Alcohol Health 
Worker and a short telephone assessment will be made about the participant’s alcohol consumption in the 
past 4 weeks using the extended AUDIT-C. If the participant is still consuming alcohol at hazardous levels a 
referral will be made to step 2 of the intervention.
Training of practice nurses to deliver behavioural change intervention
It is proposed to train two Alcohol health Workers in the techniques and delivery of a brief motivational 
behavioural change intervention. Each Alcohol Health Worker will spend 3 non-consecutive days at 
the training centre at Leeds Addiction Unit. Training will be provided by expert trainers in motivational 
interviewing. The training will take the form of simulated consultation/seminar/simulated consultation. 
Each Alcohol Health Worker will have the opportunity to engage in a simulated consultation which is 
recorded. Together the Alcohol Health Workers will discuss the simulated consultations to examine and 
review application of motivational interviewing techniques. The process of simulation/seminar/simulation 
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is repeated on a number occasions with actors who pose as a variety of potential patients. Prior to 
embarking on the study assessment of competency will be made using a recorded session rated by an 
independent expert. Alcohol Health Workers will be provided with ongoing supervision throughout the 
study provided by an expert trainer from Leeds Addiction Unit.
Screening
In accordance with guidance on best practice, all attendees at primary care who are aged 55 years or 
older, will be sent a letter explaining the study. They will be provided with an information leaflet and a 
copy of the AUDIT questionnaire. The information leaflet will provide details of the study taking place 
and make clear that completion of the screening questionnaire is not compulsory. Participants will 
have the option to not complete the questionnaire, to complete the questionnaire anonymously or 
complete the questionnaire with full contact details. Completed questionnaires will be returned to York in 
sealed envelopes.
Invitation to attend practice nurse assessment
All AUDIT positives who complete their contact details will be contacted by the Alcohol Health Worker. 
Contained within the invitation will be a detailed information leaflet providing information on the purpose 
of the study, the eligibility criteria, the proposed interventions and follow up assessments. Potential 
participants will be informed that participation is not compulsory.
Baseline assessments
At the baseline assessment the Alcohol Health Worker will discuss the study and the process of assessment 
and provide the potential participant an opportunity to ask any questions about participation in the study. 
A standard baseline assessment will be conducted and all information recorded on forms that contain 
only an identification number. Eligible participants will be invited to provide written informed consent. For 
those who do consent, randomisation will be conducted using the secure remote randomisation service at 
York Trials Unit. At this point the patients contact details and identification number will be associated and 
held on a secure server located at the University of York. This master register will be held separate from 
the outcome data and accessible only to those who need to know for purposes of conducting the study. 
Randomisation will be conducted using block randomisation stratified by cluster with an equal probability 
of receiving stepped care or minimal intervention.
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Appendix 2 Regulatory approvals
The MREC approval was obtained for the study from the North West Research Ethics Committee on 10 April 2007. LRECs were also approached in each recruitment area prior to recruitment, as were the 
relevant Research and Development departments. Approval was given at the meetings detailed in the 
table below.
Site PCT/trust LREC Approved
Research and 
development 
approval
North Yorkshire North Yorkshire & York PCT York REC 18 May 2007 16 May 2007
Hull & East Riding Hull PCT and East Riding PCT Hull & East Riding 
REC
18 May 2007 18 July 2007
Norfolk Norfolk PCT and Great 
Yarmouth and Waveney PCT
Norfolk REC 8 June 2007 4 July 2007
Norfolk Norfolk and Waveney Mental 
Health Partnership NHS Trust
Norfolk REC 12 July 2007 4 July 2007
Hull & East Riding Humber Mental Health 
Teaching NHS Trust
Hull & East Riding 
REC
28 September 2007 5 November 2007
Leeds Leeds PCT Leeds (East) REC 28 November 2007 12 June 2008
Leeds Leeds Mental Health Teaching 
NHS Trust
Leeds (East) REC 28 November 2007 12 June 2008
Fife NHS Fife Process changed 12 June 2009
Kent Eastern and Coastal Kent PCT, 
West Kent PCT
Process changed 2 August 2009
Kent Kent and Medway NHS and 
SC Partnership Trust
Process changed 3 August 2009
Tyneside NHS South of Tyne and Wear Process changed 26 August 2009
County Durham Country Durham & Tees Valley 
PCTs
Process changed 11 June 2010
Approval was gained at one additional site, but the study did not commence.
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Appendix 3 Details of study sites and practices
Centre
Practice 
ID 
number
Practice 
list size 
(approximate)
Start date in 
study
Used in-practice 
packs? (yes/no)
Used mail-
out? (yes/no)
If mail-out used, 
number sent
Leedsa 20 9883 September 2008 Yes No NA
26 11,598 June 2009 Yes No NA
27 4459 June 2009 Yes Yes 1170
28 9173 June 2009 Yes Yes 2100
35 4353 August 2009 Yes No NA
36 6552 August 2009 Yes Yes 2466
38 10,263 August 2009 Yes Yes 1610
52 5009 May 2010 No Yes 1050
53 8238 May 2010 No Yes 2139
55 9166 June 2010 No Yes 2945
59 6778 July 2010 No Yes 1700
62 6826 September 2010 No Yes 2227
63 6967 September 2010 No Yes 1432
64 11,228 September 2010 No Yes 2401
65 12,101 September 2010 No Yes 2860
North 
Yorkshire
15 13,675 July 2008 Yes No NA
16 11,486 July 2008 Yes No NA
17 5836 July 2008 Yes Yes 1831
18 16,911 July 2008 Yes No NA
21 14,387 September 2008 Yes No NA
23 16,315 December 2008 Yes No NA
Hull & 
East 
Ridinga
19 12,455 July 2008 Yes No NA
22 7300 September 2008 Yes No NA
25 3300 January 2009 Yes No NA
29 12,096 July 2009 Yes No NA
Norfolk 10 3483 January 2008 Yes No NA
12 13,365 January 2008 Yes No NA
13 2790 January 2008 Yes No NA
14 17,827 January 2008 Yes No NA
33 16,409 June 2009 Yes No NA
39 September 2009 Yes No NA
37 9795 August 2009 Yes No NA
41 7104 September 2009 Yes No NA
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Centre
Practice 
ID 
number
Practice 
list size 
(approximate)
Start date in 
study
Used in-practice 
packs? (yes/no)
Used mail-
out? (yes/no)
If mail-out used, 
number sent
Kent 30 9611 November 2009 Yes No NA
Fife 32 7249 June 2009 Yes No NA
34 4656 June 2009 Yes No NA
43 6220 September 2009 Yes No NA
44 4762 December 2009 Yes No NA
57 3799 June 2010 No Yes 1047
Tyneside 40 4500 October 2009 Yes Yes 1000
45 9300 December 2009 No Yes 2000
46 10,500 December 2009 No Yes 3500
47 4900 December 2009 No Yes 5000
48 10,009 January 2010 No Yes 3300
49 11,500 February 2010 No Yes 2600
50 2393 March 2010 No Yes 700
51 3300 March 2010 No Yes 1800
54 4171 May 2010 No Yes 1110
56 12,167 June 2010 No Yes 3377
County 
Durham
58 15,267 July 2010 No Yes 4800
60 10,445 August 2010 No Yes 2665
66 3122 September 2010 No Yes 955
67 2458 September 2010 No Yes 678
Total 53 447,457 60,463
NA, not applicable.
a One additional practice in both of the Hull and Leeds sites was set up, but no packs were ever sent out.
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Appendix 4 Patient information sheet
REC Ref: 
Short Title: PIS v1.2 
Document Name: Patient information Sheet 
Version: 1.2 
Date: 25/09/2007 
 
[Insert Header – University of York & Practice] 
 
Randomised Evaluation of a Stepped Care Treatment Approach for Older Alcohol 
Users in Primary Care. 
 
Patient Information Sheet 
 
You are being invited to take part in a research study. Before you decide whether to 
take part it is important that you understand why the research is being done and 
what taking part in the research will involve. Please find the time to read the 
following information and discuss it with family, relatives, friends or your GP if you 
wish. 
 
It is entirely up to you if you take part in the research study. If you do not wish to 
take part your usual care will not be affected in any way. If you do decide to take 
part you are free to stop taking part in the study at any time, you do not need to 
provide a reason.  
 
The research is being conducted by the University of York, in conjunction with your 
local GP practice. The research is funded by the Department of Health and the study 
has been checked by [insert ethics committee].  
 
Please read the following information carefully. If you have any questions about this 
study you can ask the practice nurse, [insert practice nurse name & telephone], or 
you can contact the study manager, [insert trial manager name and telephone]. The 
study is taking place in [No of practices] across England. We hope that 500 patients 
who are eligible will consent to take part in the study. 
 
All patients attending [insert practice details] between [start date] and [end date] 
are being asked to complete a questionnaire about how much they drink alcohol. 
You completed this questionnaire and the results indicate that you may be drinking 
more alcohol than is good for your health. [Practice nurse name] telephoned you 
and made an appointment for you to discuss the study on [insert appt date time].  
 
At the appointment [practice nurse name] will discuss the study with you. If you are 
happy to take part in the study you will be asked to sign a consent form, a copy of 
which is enclosed. [Practice Nurse Name] will ask you some questions about how 
much and when you drink alcohol, you will then be asked to fill in a short 
questionnaire about your general health and how often you use healthcare 
resources. Once this is completed the practice nurse will use a computer to decide 
what treatment you will receive. The practice nurse has no influence over the 
treatment you receive. All treatment provided will be tape recorded for quality 
assurance purposes. If you would prefer not to have your treatment session 
recorded you can indicate this on the consent form. The two treatment approaches 
are detailed below.  
 
1. Treatment 1: You will receive a short 5 minute discussion about your drinking 
with the practice nurse and some written information about alcohol and your health. 
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2. Treatment 2: You will receive a 20 minute discussion with the practice nurse 
about your drinking and explore ways in which you could reduce the amount you 
drink. About 4 weeks later the practice nurse will call and discuss how much alcohol 
you have drunk in the 4 week period. If at this time the practice nurse feels you are 
still drinking too much alcohol for your health they will invite you to see a specialist 
at the general practice for three 40-minute appointments. The specialist is trained 
in a technique called Motivational Enhancement Therapy. This approach is known to 
be effective in helping many people reduce the amount of alcohol they drink. Four 
weeks after the last of these appointments the practice nurse will again contact you 
to discuss how much alcohol you are drinking. If at this time they feel you are still 
drinking alcohol at levels that are not good for your health they will ask the general 
practitioner to make a referral to the local specialist alcohol services. 
 
Irrespective of what treatment you receive, we will send you two 
questionnaires by post. One will be sent 6 months and the other 12 months 
after the computer decided which treatment you would be receiving. These 
questionnaires will be similar to the one you completed just before your 
treatment was decided. 
 
All information collected in this study is strictly confidential. We will inform your 
general practitioner that you are taking part in the study, but if you do not want 
your GP informed you can indicate this on the consent form. At the end of the study 
we will send you a copy of the brief report outlining the results of the study. 
 
Thank you for taking the time to read this information sheet. If you need any advice 
or wish to discuss the study please feel free to contact the practice nurse, [practice 
nurse name & contact] or the trial manager at the address below. If you have any 
complaint about the study please contact the trial manager below who will deal with 
your complaint within 7 days. 
 
[Trial Manager contact details] 
 
If you are concerned about any issues related to the questions asked in this study 
or would like further information on where you can obtain help in relation to your 
drinking you can contact the National Alcohol Helpline: 
 
Freephone DrinkLine 0800-917-8282 (11am-7pm Mon - Fri). 
 
Drinkline offers the following services: 
• Information and self-help materials. 
• Help to callers worried about their own drinking. 
• Support to the family and friends of people who are drinking. 
• Advice to callers on where to go for help. 
 
Drinkline is confidential and no names need be given. Callers to the above number 
have the option of listening to recorded information about alcohol or talking to an 
adviser. 
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Appendix 5 Screening questionnaire
 [Insert Header – Practice] 
 
 
Dear patient 
 
We are asking all patients, aged 55 years or older, to complete a questionnaire 
about how much alcohol they drink. You should have received a copy of the 
questionnaire and an envelope from the receptionist when you came for your 
appointment. 
 
We would be grateful if you would complete both sides of the questionnaire and then 
place the completed questionnaire in the envelope, seal it and place in the box by 
the practice reception, or if you prefer to complete the questionnaire at home return 
it in the stamped addressed envelope provided..  
 
We are conducting a study in the practice looking at how much alcohol people drink 
and looking at different treatments for those who are drinking more alcohol than is 
good for their health. If you are happy to help us in this study please enter your 
name and address on the questionnaire. The practice nurse may contact you within 
the next week to discuss the study with you or to ask you to complete an additional 
questionnaire. 
 
If you do wish to be considered for the study please complete the questionnaire and 
complete the name and address section. The practice nurse will contact you in 
the near future about participation. 
 
All returned questionnaires will be treated in strictest confidence.  
 
Many thanks for reading this letter. 
 
Yours truly, 
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The following questionnaire asks a few questions about you and about how much 
alcohol you drink. Please answer the questions on this side of the paper and then 
turn over the paper and answer the questions on the other side. The questionnaire 
should only take a few minutes to complete. 
 
If you are willing to be considered for our research study please enter your 
name, address and telephone number in the box below. If you do not wish to be 
considered for our research study leave the box below empty and continue to 
complete the questionnaire. 
 
 
 
 
 
 
 
 
 
 
 
Please answer the following questions then turn over the page 
 
 
 
1. What is your age?  
 
 
 
2. Are you male or female? Male  Female  
 
 
 
Now please answer the questions overleaf… 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name, Address and Telephone 
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For each of the 10 questions please put a cross in the box below the answer that is correct for you.  
 
1. How often do you have a drink containing alcohol? 
Never Monthly or 
less 
2 to 4 times a 
month 
2 to 3 times a 
week 
4 or more 
times a week 
     
 
2. If you drink alcohol. How many drinks, containing alcohol do you have on a typical day when 
you are drinking? 
A drink is half a pint of normal bitter, lager or cider or a small glass of wine or a small measure of 
spirits. 
1 or 2 3 or 4 5 or 6 7 to 9 10 or more 
     
 
3. How often do you have 6 or more drinks on a single occasion? 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost daily 
     
 
4. How many times in the past year have you found that you were not able to stop drinking after 
you had started? 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost daily 
     
 
5. How often during the last year have you failed to do what was normally expected of you 
because of your drinking? 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost daily 
     
 
6. How often during the last year have you needed a first drink in the morning to get yourself 
going after a heavy drinking session? 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost daily 
     
 
7. How often during the last year have you had guilt or remorse after drinking? 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost daily 
     
 
8. How often during the last year have you been unable to remember what happened the night 
before because you have been drinking? 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost daily 
     
 
9. Have you, or someone else been injured as a result of your drinking? 
No Yes, but not in the last 
year 
Yes during the last year 
   
 
10. Has a relative, friend, doctor or other health worker been concerned about your drinking and 
suggested you cut down? 
No Yes, but not in the last 
year 
Yes during the last year 
   
 

© Queen’s Printer and Controller of HMSO 2013. This work was produced by Watson et al. under the terms of a commissioning contract issued by the Secretary of State for 
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
DOI: 10.3310/hta17250 HealtH tecHnOlOgy assessment 2013 VOl. 17 nO. 25
95
Appendix 6 Data collection booklets
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Appendix 7 Intervention delivery by site
Centre Practice ID number
Minimal intervention and
Step 1 delivered by Step 2 delivered by
Leedsa 20 Practice nurse Specialist addiction services 
therapist
26 Practice nurse
27 Alcohol development nurse, then 
research practitioner A
28
35 Alcohol development nurse, then 
research practitioner B
36 Alcohol development nurse, then 
research practitioner A
38 Alcohol development nurse, then 
research practitioner B
52 Research practitioner B
53
55
59 Research practitioner A
62 Research practitioner B
63 Research practitioner A
64 Research practitioner B
65 Research practitioner A
North Yorkshire 15 Practice nurse Drug and alcohol counsellor
16 Practice nurse
17 Research practice nurse Alcohol service manager
18
21 Practice nurse
23 Practice nurse and practice nurse 
manager
Hull & East Ridinga 19 Practice nurses × 2 Clinical nurse manager (addiction 
services)
22 Practice nurse and nurse practitioner
25 Practice nurse
29 Practice nurses × 2
Norfolk 10 Practice nurse, then a research nurse GP liaison nurses × 2 (alcohol and 
drugs service)
12 Practice nurse, then a research nurse
13 Research nurse
14
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Centre Practice ID number
Minimal intervention and
Step 1 delivered by Step 2 delivered by
33
39
37
41
Kent 30 Practice nurse Counsellor for drug and alcohol 
community services
Fife 32 Research nurses × 2 Same research nurses × 2
34
43
44
57
Tyneside 40 Alcohol health workers × 2 Same alcohol health workers
45
46
47
48
49
50
51
54
56
County Durham 58 Alcohol health workers × 2 Same alcohol health workers
60
66
67
a The Hull and Leeds sites each had one additional practice set up, but no packs were ever distributed.
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Appendix 8 Safer drinking leaflet
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Appendix 9 Study summary
All primary care attendees aged 55 years or above collected screening pack at practice; or
all patients on practice list aged 55 years or above mailed a screening pack
Patient did not complete Patient completed and
returned anonymously
Patient completed form and returned
with contact details
No further
action
No further
action
Positive screen nurse contacted
patient, informed them that they
appear to meet eligibility criteria,
mades appointment if possible.
Sent sample consent form and
information sheet
Negative screen
anonymous AUDIT
data incorporated into
representativeness
analysis
Anonymous
AUDIT data
incorporated into
representativeness
analysis
Patient attended;
willing to
participate, gave
written consent and
completed baseline
questionnaire
Patient did
not attend
Randomised to minimal intervention
delivered at practice
Randomised to stepped care behavioural
change counselling delivered at practice
(step 1)
28-day post-step 1 assessment made by
telephone
Non-hazardous
consumption
No further treatment
Non-hazardous
consumption
No further treatment
Hazardous consumption
Referred to step 2. MET delivered by
therapist at practice
28-day post-step 2 assessment made by
telephone
Hazardous consumption
Referred to step 3
Specialist alcohol services
Postal follow-up at month 6 plus reminders
Postal follow-up at month 12 plus reminders
Appointment
made
Patient sent outcome letter and
additional questionnaire.
No reminders
Patient
refused
appointment
logged off on
system
Patient
attended,
but did not
consent
Logged as
having
attended,
but not
consented
Remained on system for
two more contact attempts
If three × contacts failed or three
appointments not attended,
logged off. No further action
Patient randomised online
or by telephone
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Appendix 10 AESOPS Process Rating Scale
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AESOPS PRS SHEET 
 
Session Management 
 
1) Maintaining Structure 
Frequency:  
Quality:  
2) Agenda Setting       
Frequency:  
Quality:  
3) Consistency of Problem Focus  
Frequency:  
Quality:  
4) End of Session Summary 
Frequency:  
Quality:  
 
Specific Tasks 
 
5) Drinking – Feedback/Negative Consequences 
Frequency:  
Quality:  
6) Eliciting Client Concerns about Drinking 
Frequency:  
Quality:  
7) Eliciting Self-efficacy for Change  
Frequency:  
Quality:  
8) Commitment to Drinking Goal 
Frequency:  
Quality:  
9) Ambivalence 
Frequency:  
Quality:  
10) Creating Conflict 
Frequency:  
Quality:  
11) Eliciting Commitment to Change Drinking 
Frequency:  
Quality:  
Duration:  
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12) Eliciting Optimism for Change 
Frequency:  
Quality:  
 
Therapist Style 
 
13) Reflective Listening 
Frequency:  
Quality:  
14) Empathy 
Frequency:  
Quality:  
15) Unsolicited Advice  
Frequency:  
16) Open Questions 
Frequency:  
Quality:  
17) Closed Questions 
Frequency:  
 
18) Session content 
 
Please tick appropriate box for the following: 
Content/Activity Yes No 
Review AUDIT score   
Obtain an account of drinking   
Give correct advice/Information   
Set a target   
Make a drinking plan   
 
Additional Comments: Please tick appropriate box for the following: 
Tape Quality Sound 
Poor …… 
Good …… 
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Appendix 11 Mail-out documentation
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REC Ref: 
Short Title: AUDIT-v2 
Document Name: AUDIT Screening Questionnaire 
Version: 2 (Newcastle) 
Date: 16/06/2009 
 
[Insert Header – Practice] 
 
 
Dear patient 
 
We are asking all patients, aged 55 years or older, to complete a questionnaire about how 
much alcohol they drink.  
 
We would be grateful if you would complete both sides of the questionnaire and then place 
the completed questionnaire in the envelope, seal it and return it in the enclosed prepaid 
envelope.  
 
We are conducting a study in the practice looking at how much alcohol people drink and 
looking at different treatments for those who are drinking more alcohol than is good for their 
health. If you are happy to help us in this study please enter your name and address on the 
questionnaire. Someone may contact you within the next week to discuss the study with you 
or to ask you to complete an additional questionnaire. 
 
If you do not wish to be considered for the study please complete the questionnaire and do 
not complete the name and address section. 
 
All returned questionnaires will be treated in strictest confidence.  
 
Many thanks for reading this letter. 
 
Yours truly, 
 
[insert signatories]    
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REC Ref: 
Short Title: v2.1 
Document Name: AUDIT Screening Questionnaire 
Version: 3 (Mailout) 
Date: 17/09/09 
 
[Insert Header – Practice] 
 
 
Dear patient 
 
We are asking all patients, aged 55 years or older, to complete a questionnaire about how 
much alcohol they drink.  
 
We would be grateful if you would complete both sides of the questionnaire and then place 
the completed questionnaire in the envelope, seal it and return it in the enclosed prepaid 
envelope.  
 
We are conducting a study in the practice looking at how much alcohol people drink and 
looking at different treatments for those who are drinking more alcohol than is good for their 
health. If you are happy to help us in this study please enter your name and address on the 
questionnaire. The practice nurse or research nurse may contact you within the next week to 
discuss the study with you or to ask you to complete an additional questionnaire. 
 
If you do not wish to be considered for the study please complete the questionnaire and do 
not complete the name and address section. 
 
All returned questionnaires will be treated in strictest confidence.  
 
Many thanks for reading this letter. 
 
Yours truly, 
 
[insert signatory]    
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